{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T01:48:08Z","timestamp":1788659288459,"version":"build-2803163510"},"reference-count":340,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-56976"],"award-info":[{"award-number":["MOP-56976"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>HIV associated neurocognitive disorders (HAND) are the spectrum of cognitive impairments present in patients infected with human immunodeficiency virus type 1 (HIV-1). The number of patients affected with HAND ranges from 30 to 50% of HIV infected individuals and although the development of combinational antiretroviral therapy (cART) has improved longevity, HAND continues to pose a significant clinical problem as the current standard of care does not alleviate or prevent HAND symptoms. At present, the pathological mechanisms contributing to HAND remain unclear, but evidence suggests that it stems from neuronal injury due to chronic release of neurotoxins, chemokines, viral proteins, and proinflammatory cytokines secreted by HIV-1 activated microglia, macrophages and astrocytes in the central nervous system (CNS). Furthermore, the blood\u2013brain barrier (BBB) not only serves as a route for HIV-1 entry into the brain but also prevents cART therapy from reaching HIV-1 brain reservoirs, and therefore could play an important role in HAND. The goal of this review is to discuss the current data on the epidemiology, pathology and research models of HAND as well as address the potential pharmacological treatment approaches that are being investigated.<\/jats:p>","DOI":"10.1186\/s12987-020-00204-5","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T03:03:42Z","timestamp":1594350222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders"],"prefix":"10.1186","volume":"17","author":[{"given":"Amila","family":"Omeragic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olanre","family":"Kayode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Tozammel","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Bendayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"204_CR1","unstructured":"Unaids. UNAIDS DATA 2018; 2018. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/unaids-data-2018_en.pdf. Accessed 7 Aug 2018."},{"issue":"2","key":"204_CR2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/NRL.0b013e318247bc7a","volume":"18","author":"RE Cecilia","year":"2012","unstructured":"Cecilia RE, Ovidiu R, Mihaela S, Dana CR. HIV-associated neurocognitive disorders. Neurologist. 2012;18(2):64\u20137.","journal-title":"Neurologist."},{"issue":"6","key":"204_CR3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.410190602","volume":"19","author":"BA Navia","year":"1986","unstructured":"Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986;19(6):517\u201324.","journal-title":"Ann Neurol."},{"key":"204_CR4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Becker N. Updated research nosology for HIV-associated neuro cognitive disorders. Neurology. 2007;69:1789\u201399.","journal-title":"Neurology."},{"key":"204_CR5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1212\/WNL.0000000000002277","volume":"86","author":"N Sacktor","year":"2015","unstructured":"Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, et al. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology. 2015;86:334\u201340.","journal-title":"Neurology."},{"issue":"4","key":"204_CR6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, et al. HIV-associated neurocognitive disorder\u2014pathogenesis and prospects for treatment. Nat Rev Neurol. 2016;12(4):234\u201348.","journal-title":"Nat Rev Neurol."},{"key":"204_CR7","first-page":"407","volume-title":"Neuroimmune Pharmacology","author":"H Fox","year":"2016","unstructured":"Fox H, Purnell P. HIV-associated neurocognitive disorders. Neuroimmune Pharmacology. Cham: Springer; 2016. p. 407\u201320."},{"issue":"4","key":"204_CR8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1176\/appi.neuropsych.13080178","volume":"26","author":"K Goodkin","year":"2014","unstructured":"Goodkin K, Hardy DJ, Singh D, Lopez E. Diagnostic utility of the international HIV dementia scale for HIV-associated neurocognitive impairment and disorder in South Africa. J Neuropsychiatry Clin Neurosci. 2014;26(4):352\u20138.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"204_CR9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/2325957414553839","volume":"16","author":"A Jika Yusuf","year":"2017","unstructured":"Jika Yusuf A, Hassan A, Indo Mamman A, Mohammed Muktar H, Maude Suleiman A, Baiyewu O. HIV clinical management prevalence of HIV-associated neurocognitive disorder (HAND) among patients attending a tertiary health facility in northern nigeria. J Int Assoc Provid AIDS Care. 2017;16(1):48\u201355.","journal-title":"J Int Assoc Provid AIDS Care."},{"key":"204_CR10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13365-017-0556-6","volume":"24","author":"N Sacktor","year":"2018","unstructured":"Sacktor N. Changing clinical phenotypes of HIV-associated neurocognitive disorders. J Neurovirol. 2018;24:141\u20135.","journal-title":"J Neurovirol."},{"issue":"1","key":"204_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, LeBlanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3\u201316.","journal-title":"J Neurovirol."},{"issue":"23","key":"204_CR12","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: charter Study. Neurology. 2010;75(23):2087\u201396.","journal-title":"Neurology."},{"issue":"23","key":"204_CR13","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1212\/WNL.0000000000000492","volume":"82","author":"I Grant","year":"2014","unstructured":"Grant I, Franklin DR, Deutsch R, Woods SP, Vaida F, Ellis RJ, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014;82(23):2055\u201362.","journal-title":"Neurology."},{"issue":"01","key":"204_CR14","doi-asserted-by":"crossref","first-page":"021","DOI":"10.1055\/s-0034-1372339","volume":"34","author":"K Robertson","year":"2014","unstructured":"Robertson K, Yosief S. Neurocognitive assessment in the diagnosis of HIV-associated neurocognitive disorders. Semin Neurol. 2014;34(01):021\u20136.","journal-title":"Semin Neurol"},{"issue":"1","key":"204_CR15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-0034-1372346","volume":"34","author":"MC Masters","year":"2014","unstructured":"Masters MC, Ances BM. Role of neuroimaging in HIV-associated neurocognitive disorders. Semin Neurol. 2014;34(1):89\u2013102.","journal-title":"Semin Neurol"},{"issue":"3","key":"204_CR16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/QAD.0b013e32835b1019","volume":"27","author":"F Bonnet","year":"2013","unstructured":"Bonnet F, Amieva H, Marquant F, Bernard C, Bruyand M, Dauchy FA, et al. Cognitive disorders in HIV-infected patients: are they HIV-related? Aids. 2013;27(3):391\u2013400.","journal-title":"Aids."},{"issue":"19","key":"204_CR17","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1212\/WNL.0b013e318291903f","volume":"80","author":"KJ Kallianpur","year":"2013","unstructured":"Kallianpur KJ, Shikuma C, Kirk GR, Shiramizu B, Valcour V, Chow D, et al. Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter. Neurology. 2013;80(19):1792\u20139.","journal-title":"Neurology."},{"issue":"5","key":"204_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAD.0000000000000580","volume":"29","author":"AM Dickens","year":"2015","unstructured":"Dickens AM, Anthony DC, Deutsch R, Mielke MM, Claridge TDW, Grant I, et al. Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients. AIDS. 2015;29(5):1.","journal-title":"AIDS."},{"key":"204_CR19","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1212\/WNL.0b013e3182a9565e","volume":"81","author":"VVR Bandaru","year":"2013","unstructured":"Bandaru VVR, Mielke MM, Sacktor N, Mcarthur JC, Grant I, Letendre S, et al. A lipid storage\u2014like disorder contributes to cognitive decline in HIV-infected subjects. Neurology. 2013;81:1492\u20139.","journal-title":"Neurology."},{"issue":"4","key":"204_CR20","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.neuroimage.2004.07.067","volume":"23","author":"L Chang","year":"2004","unstructured":"Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, et al. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage. 2004;23(4):1336\u201347.","journal-title":"Neuroimage."},{"issue":"1","key":"204_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-6405-7-15","volume":"7","author":"L Hagberg","year":"2010","unstructured":"Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, et al. Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther. 2010;7(1):1\u201312.","journal-title":"AIDS Res Ther."},{"issue":"3","key":"204_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000036","volume":"1","author":"DW Williams","year":"2014","unstructured":"Williams DW, Byrd D, Rubin LH, Anastos K, Morgello S, Berman JW. CCR2 on CD14+CD16+monocytes is a biomarker of HIV-associated neurocognitive disorders. Neurol Neuroimmunol Neuroinflamm. 2014;1(3):1\u20139.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"204_CR23","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.4049\/jimmunol.178.10.6581","volume":"178","author":"PJ Ellery","year":"2007","unstructured":"Ellery PJ, Tippett E, Chiu Y-L, Paukovics G, Cameron PU, Solomon A, et al. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol. 2007;178(10):6581\u20139.","journal-title":"J Immunol."},{"issue":"5","key":"204_CR24","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s11481-013-9512-2","volume":"8","author":"E Cassol","year":"2013","unstructured":"Cassol E, Misra V, Morgello S, Gabuzda D. Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection. J Neuroimmune Pharmacol. 2013;8(5):1087\u201397.","journal-title":"J Neuroimmune Pharmacol."},{"issue":"12","key":"204_CR25","doi-asserted-by":"crossref","first-page":"e116081","DOI":"10.1371\/journal.pone.0116081","volume":"9","author":"J Peterson","year":"2014","unstructured":"Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L, et al. Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS ONE. 2014;9(12):e116081.","journal-title":"PLoS ONE"},{"issue":"8","key":"204_CR26","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s00415-006-0481-8","volume":"254","author":"S Abdulle","year":"2007","unstructured":"Abdulle S, Mellgren \u00c5, Brew BJ, Cinque P, Hagberg L, Price RW, et al. CSF neurofilament protein (NFL)\u2014a marker of active HIV-related neurodegeneration. J Neurol. 2007;254(8):1026\u201332.","journal-title":"J Neurol"},{"issue":"1","key":"204_CR27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","volume":"987","author":"N Norgren","year":"2003","unstructured":"Norgren N, Rosengren L, Stigbrand T. Elevated neurofilament levels in neurological diseases. Brain Res. 2003;987(1):25\u201331.","journal-title":"Brain Res"},{"issue":"4","key":"204_CR28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s13365-015-0333-3","volume":"21","author":"JL McGuire","year":"2015","unstructured":"McGuire JL, Gill AJ, Douglas SD, Kolson DL. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J Neurovirol. 2015;21(4):439\u201348.","journal-title":"J Neurovirol."},{"issue":"1","key":"204_CR29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12974-017-0794-9","volume":"14","author":"J Nitkiewicz","year":"2017","unstructured":"Nitkiewicz J, Borjabad A, Morgello S, Murray J, Chao W, Emdad L, et al. HIV induces expression of complement component C3 in astrocytes by NF-\u03baB-dependent activation of interleukin-6 synthesis. J Neuroinflamm. 2017;14(1):23.","journal-title":"J Neuroinflamm"},{"issue":"3","key":"204_CR30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1468-1293.2012.01044.x","volume":"14","author":"M Fabbiani","year":"2013","unstructured":"Fabbiani M, Ciccarelli N, Tana M, Farina S, Baldonero E, Di Cristo V, et al. Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med. 2013;14(3):136\u201344.","journal-title":"HIV Med."},{"issue":"5","key":"204_CR31","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/01.WNL.0000134665.58343.8D","volume":"63","author":"V Valcour","year":"2004","unstructured":"Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology. 2004;63(5):822\u20137.","journal-title":"Neurology."},{"issue":"6","key":"204_CR32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s13365-017-0580-6","volume":"23","author":"E Kinai","year":"2017","unstructured":"Kinai E, Komatsu K, Sakamoto M, Taniguchi T, Nakao A, Igari H, et al. Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study. J Neurovirol. 2017;23(6):864\u201374.","journal-title":"J Neurovirol."},{"issue":"7","key":"204_CR33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/NBHIV.S17408","volume":"33","author":"R Gonzalez","year":"2012","unstructured":"Gonzalez R, Schuster. Substance abuse, hepatitis C, and aging in HIV: common cofactors that contribute to neurobehavioral disturbances. Neurobehav HIV Med. 2012;33(7):15.","journal-title":"Neurobehav HIV Med."},{"issue":"7","key":"204_CR34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/13803395.2011.553584","volume":"33","author":"R Gonzalez","year":"2011","unstructured":"Gonzalez R, Schuster RM, Vassileva J, Martin EM. Impact of HIV and a history of marijuana dependence on procedural learning among individuals with a history of substance dependence. J Clin Exp Neuropsychol. 2011;33(7):735\u201352.","journal-title":"J Clin Exp Neuropsychol"},{"key":"204_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/641913","volume":"2015","author":"EM Tedaldi","year":"2015","unstructured":"Tedaldi EM, Minniti NL, Fischer T. HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities. Biomed Res Int. 2015;2015:1\u201313.","journal-title":"Biomed Res Int"},{"issue":"6","key":"204_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a007120","volume":"2","author":"S Spudich","year":"2012","unstructured":"Spudich S, Gonz\u00e1lez-Scarano F. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment. Cold Spring Harb Perspect Med. 2012;2(6):1\u201317.","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"8","key":"204_CR37","doi-asserted-by":"crossref","first-page":"a006866","DOI":"10.1101\/cshperspect.a006866","volume":"2","author":"CB Wilen","year":"2012","unstructured":"Wilen CB, Tilton JC, Doms RW. HIV: cell binding and entry. Cold Spring Harb Perspect Med. 2012;2(8):a006866.","journal-title":"Cold Spring Harb Perspect Med."},{"key":"204_CR38","doi-asserted-by":"crossref","unstructured":"Shepherd JC, Jacobson LP, Qiao W, Jamieson BD, Phair JP, Piazza P, et al. Emergence and persistence of CXCR4-tropic HIV-1 in a population of men from the multicenter AIDS cohort study; 2008. http:\/\/www.statepi. Accessed 6 Sept 2018.","DOI":"10.1086\/591623"},{"issue":"3","key":"204_CR39","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s13365-014-0287-x","volume":"21","author":"SB Joseph","year":"2015","unstructured":"Joseph SB, Arrildt KT, Sturdevant CB, Swanstrom R. HIV-1 target cells in the CNS. J Neurovirol. 2015;21(3):276\u201389.","journal-title":"J Neurovirol."},{"issue":"14","key":"204_CR40","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1097\/QAD.0b013e32833c543f","volume":"24","author":"J Toma","year":"2010","unstructured":"Toma J, Whitcomb JM, Petropoulos CJ, Huang W. Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors. Aids. 2010;24(14):2181\u20136.","journal-title":"Aids."},{"issue":"2","key":"204_CR41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jis326","volume":"206","author":"V Valcour","year":"2012","unstructured":"Valcour V, Chalermchai T, Sailasuta N, Marovich M, Lerdlum S, Suttichom D, et al. Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis. 2012;206(2):275\u201382.","journal-title":"J Infect Dis"},{"issue":"13","key":"204_CR42","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/JVI.76.13.6689-6700.2002","volume":"76","author":"NQ Liu","year":"2002","unstructured":"Liu NQ, Lossinsky AS, Popik W, Li X, Gujuluva C, Kriederman B, et al. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J Virol. 2002;76(13):6689\u2013700.","journal-title":"J Virol"},{"issue":"5","key":"204_CR43","doi-asserted-by":"crossref","first-page":"e01280-17","DOI":"10.1128\/mBio.01280-17","volume":"8","author":"M Veenstra","year":"2017","unstructured":"Veenstra M, Le\u00f3n-Rivera R, Li M, Gama L, Clements JE, Berman JW. Mechanisms of CNS viral seeding by HIV+ CD14+CD16+ monocytes: establishment and reseeding of viral reservoirs contributing to HIV-associated neurocognitive disorders. MBio. 2017;8(5):e01280-17.","journal-title":"MBio."},{"issue":"6","key":"204_CR44","first-page":"e69270","volume":"8","author":"DW Williams","year":"2013","unstructured":"Williams DW, Calderon TM, Lopez L, Carvallo-Torres L, Gaskill PJ, Eugenin EA, et al. Mechanisms of HIV Entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis. Public Libr Sci ONE. 2013;8(6):e69270.","journal-title":"Public Libr Sci ONE."},{"issue":"9053","key":"204_CR45","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(96)10178-1","volume":"349","author":"L Pulliam","year":"1997","unstructured":"Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS. Unique monocyte subset in patients with AIDS dementia. Lancet. 1997;349(9053):692\u20135.","journal-title":"Lancet"},{"key":"204_CR46","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1002\/eji.1830251232","volume":"25","author":"N Thieblemont","year":"1995","unstructured":"Thieblemont N, Weiss L, Sadeghi HM, Estcourt C, Haeffner-Cavaillon N. CD1410wCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol. 1995;25:3418\u201324.","journal-title":"Eur J Immunol"},{"issue":"2","key":"204_CR47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1189\/jlb.5A0714-347R","volume":"97","author":"DW Williams","year":"2015","unstructured":"Williams DW, Anastos K, Morgello S, Berman JW. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol. 2015;97(2):401\u201312.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"204_CR48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.immuni.2014.08.014","volume":"41","author":"N Calantone","year":"2014","unstructured":"Calantone N, Wu F, Klase Z, Deleage C, Perkins M, Matsuda K, et al. Tissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cells. Immunity. 2014;41(3):493\u2013502.","journal-title":"Immunity"},{"issue":"6","key":"204_CR49","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.chom.2014.10.010","volume":"16","author":"AE Baxter","year":"2014","unstructured":"Baxter AE, Russell RA, Duncan CJA, Moore MD, Willberg CB, Pablos JL, et al. Macrophage infection via selective capture of HIV-1-infected CD4+ T cells. Cell Host Microbe. 2014;16(6):711\u201321.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"204_CR50","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1172\/JCI84456","volume":"126","author":"JB Honeycutt","year":"2016","unstructured":"Honeycutt JB, Wahl A, Baker C, Spagnuolo RA, Foster J, Zakharova O, et al. Macrophages sustain HIV replication in vivo independently of T cells. J Clin Invest. 2016;126(4):1353\u201366.","journal-title":"J Clin Invest."},{"issue":"5","key":"204_CR51","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1172\/JCI112491","volume":"77","author":"DD Ho","year":"1986","unstructured":"Ho DD, Rota TR, Hirsch MS. Infection of monocyte\/macrophages by human T lymphotropic virus type III. J Clin Invest. 1986;77(5):1712\u20135.","journal-title":"J Clin Invest."},{"issue":"9","key":"204_CR52","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1371\/journal.ppat.0030134","volume":"3","author":"S Swingler","year":"2007","unstructured":"Swingler S, Mann AM, Zhou J, Swingler C, Stevenson M. Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog. 2007;3(9):e134.","journal-title":"PLoS Pathog."},{"key":"204_CR53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.addr.2016.05.001","volume":"103","author":"C Alam","year":"2016","unstructured":"Alam C, Whyte-Allman S-K, Omeragic A, Bendayan R. Role and modulation of drug transporters in HIV-1 therapy. Adv Drug Deliv Rev. 2016;103:121\u201343.","journal-title":"Adv Drug Deliv Rev"},{"issue":"24","key":"204_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.01237-17","volume":"91","author":"L Bracq","year":"2017","unstructured":"Bracq L, Xie M, Lambel\u00e9 M, Vu L-T, Matz J, Schmitt A, et al. T Cell-macrophage fusion triggers multinucleated giant cell formation for HIV-1 spreading. J Virol. 2017;91(24):1\u201319.","journal-title":"J Virol"},{"key":"204_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2019.00362","volume":"9","author":"C Wallet","year":"2019","unstructured":"Wallet C, De Rovere M, Van Assche J, Daouad F, De Wit S, Gautier V, et al. Microglial cells: the main HIV-1 reservoir in the brain. Front Cell Infect Microbiol. 2019;9:1\u201318.","journal-title":"Front Cell Infect Microbiol."},{"issue":"2","key":"204_CR56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2990.1991.tb00707.x","volume":"17","author":"C Geny","year":"1991","unstructured":"Geny C, Gherardi R, Boudes P, Lionnet F, Cesaro P, Gray F. Multifocal multinucleated giant cell myelitis in an AIDS patient. Neuropathol Appl Neurobiol. 1991;17(2):157\u201362.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"204_CR57","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/modpathol.3880237","volume":"13","author":"J-L Dargent","year":"2000","unstructured":"Dargent J-L, Lespagnard L, Kornreich A, Hermans P, Clumeck N, Verhest A. HIV-associated multinucleated giant cells in lymphoid tissue of the Waldeyer\u2019s ring: a detailed study. Mod Pathol. 2000;13(12):1293\u20139.","journal-title":"Mod Pathol"},{"issue":"1","key":"204_CR58","first-page":"75","volume":"12","author":"M Lewin-Smith","year":"1999","unstructured":"Lewin-Smith M, Wahl SM, Orenstein JM. Human immunodeficiency virus-rich multinucleated giant cells in the colon: a case report with transmission electron microscopy, immunohistochemistry, and in situ hybridization. Mod Pathol. 1999;12(1):75\u201381.","journal-title":"Mod Pathol"},{"issue":"1","key":"204_CR59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/viro.2002.1395","volume":"297","author":"EV Ryzhova","year":"2002","unstructured":"Ryzhova EV, Crino P, Shawver L, Westmoreland SV, Lackner AA, Gonz\u00e1lez-Scarano F. Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples. Virology. 2002;297(1):57\u201367.","journal-title":"Virology"},{"issue":"5","key":"204_CR60","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.ajpath.2011.01.023","volume":"178","author":"C Soulas","year":"2011","unstructured":"Soulas C, Conerly C, Kim W-K, Burdo TH, Alvarez X, Lackner AA, et al. Recently infiltrating MAC387+ monocytes\/macrophages. Am J Pathol. 2011;178(5):2121\u201335.","journal-title":"Am J Pathol"},{"issue":"4","key":"204_CR61","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1128\/jvi.71.4.2928-2933.1997","volume":"71","author":"I Teo","year":"1997","unstructured":"Teo I, Veryard C, Barnes H, An SF, Jones M, Lantos PL, et al. Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. J Virol. 1997;71(4):2928\u201333.","journal-title":"J Virol"},{"issue":"2","key":"204_CR62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000330987","volume":"43","author":"B Vicandi","year":"1999","unstructured":"Vicandi B, Jim\u00e9nez-Heffernan JA, L\u00f3pez-Ferrer P, Patr\u00f3n M, Gamallo C, Colmenero C, et al. HIV-1 (p24)-positive multinucleated giant cells in HIV-associated lymphoepithelial lesion of the parotid gland. Acta Cytol. 1999;43(2):247\u201351.","journal-title":"Acta Cytol"},{"issue":"3","key":"204_CR63","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1176\/jnp.2010.22.3.321","volume":"22","author":"EM Warriner","year":"2010","unstructured":"Warriner EM, Rourke SB, Rourke BP, Rubenstein S, Millikin C, Buchanan L, et al. Immune activation and neuropsychiatric symptoms in HIV infection. J Neuropsychiatry Clin Neurosci. 2010;22(3):321\u20138.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"204_CR64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-2094-11-91","volume":"11","author":"T Ashraf","year":"2014","unstructured":"Ashraf T, Jiang W, Hoque M, Henderson J, Wu C, Bendayan R. Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation. J Neuroinflamm. 2014;11(1):91.","journal-title":"J Neuroinflamm"},{"issue":"6","key":"204_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0039565","volume":"7","author":"S Dohgu","year":"2012","unstructured":"Dohgu S, Ryerse JS, Robinson SM, Banks WA. Human immunodeficiency virus-1 uses the mannose-6-phosphate receptor to cross the blood-brain barrier. PLoS ONE. 2012;7(6):1\u201312.","journal-title":"PLoS ONE"},{"issue":"1","key":"204_CR66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10571-004-1383-x","volume":"25","author":"M Toborek","year":"2005","unstructured":"Toborek M, Lee YW, Flora G, Pu H, Andr\u00e1s IE, Wylegala E, et al. Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell Mol Neurobiol. 2005;25(1):181\u201399.","journal-title":"Cell Mol Neurobiol"},{"issue":"01","key":"204_CR67","first-page":"255","volume":"04","author":"H Xiong","year":"2013","unstructured":"Xiong H, Ton H. Astrocyte dysfunctions and HIV-1 neurotoxicity. J AIDS Clin Res. 2013;04(01):255.","journal-title":"J AIDS Clin Res."},{"issue":"9","key":"204_CR68","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/sj.jcbfm.9600115","volume":"25","author":"IE Andr\u00e1s","year":"2005","unstructured":"Andr\u00e1s IE, Pu H, Tian J, Deli MA, Nath A, Hennig B, et al. Signaling mechanisms of HIV-1 Tat-induced alterations of Claudin-5 expression in brain endothelial cells. J Cereb Blood Flow Metab. 2005;25(9):1159\u201370.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"204_CR69","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/sj.jcbfm.9600125","volume":"25","author":"H Pu","year":"2005","unstructured":"Pu H, Tian J, Andras IE, Hayashi K, Flora G, Hennig B, et al. HIV-1 Tat protein-induced alterations of ZO-1 expression are mediated by redox-regulated ERK1\/2 activation. J Cereb Blood Flow Metab. 2005;25(10):1325\u201335.","journal-title":"J Cereb Blood Flow Metab"},{"key":"204_CR70","doi-asserted-by":"publisher","unstructured":"Johnsen AR, Jacobsen OS, Gudmundsson L, Albers CN. Erratum to: Chloroform emissions from arctic and subarctic ecosystems in Greenland and Northern Scandinavia (Biogeochemistry, https:\/\/doi.org\/10.1007\/s10533-016-0241-5). Biogeochemistry. 2016;130(1\u20132):67.","DOI":"10.1007\/s10533-016-0241-5"},{"issue":"6","key":"204_CR71","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnen\/64.6.498","volume":"64","author":"GD Kanmogne","year":"2005","unstructured":"Kanmogne GD, Primeaux C, Grammas P. HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J Neuropathol Exp Neurol. 2005;64(6):498\u2013505.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"204_CR72","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/13550280009091950","volume":"6","author":"H Chen","year":"2000","unstructured":"Chen H, Wood C, Petito CK. Comparisons of HIV-1 viral sequences in brain, choroid plexus and spleen: potential role of choroid plexus in the pathogenesis of HIV encephalitis. J Neurovirol. 2000;6(6):498\u2013506.","journal-title":"J Neurovirol."},{"issue":"7","key":"204_CR73","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/01.aids.0000166090.31693.aa","volume":"19","author":"EJ Burkala","year":"2005","unstructured":"Burkala EJ, He J, West JT, Wood C, Petito CK. Compartmentalization of HIV-1 in the central nervous system: role of the choroid plexus. Aids. 2005;19(7):675\u201384.","journal-title":"Aids."},{"issue":"1","key":"204_CR74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.meegid.2010.10.016","volume":"11","author":"SL Lamers","year":"2011","unstructured":"Lamers SL, Gray RR, Salemi M, Huysentruyt LC, McGrath MS. HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues. Infect Genet Evol. 2011;11(1):31\u20137.","journal-title":"Infect Genet Evol."},{"issue":"1","key":"204_CR75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cen3.12563","volume":"11","author":"S Pal","year":"2020","unstructured":"Pal S, Rao S, Louveau A. Meningeal lymphatic network: the middleman of neuroinflammation. Clin Exp Neuroimmunol. 2020;11(1):21\u20135.","journal-title":"Clin Exp Neuroimmunol."},{"issue":"1","key":"204_CR76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/embj.201386609","volume":"33","author":"M Schwartz","year":"2014","unstructured":"Schwartz M, Baruch K. The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J. 2014;33(1):7\u201322.","journal-title":"EMBO J"},{"issue":"12","key":"204_CR77","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","volume":"40","author":"NA Jessen","year":"2015","unstructured":"Jessen NA, Munk ASF, Lundgaard I, Nedergaard M. The glymphatic system: a beginner\u2019s guide. Neurochem Res. 2015;40(12):2583\u201399.","journal-title":"Neurochem Res"},{"issue":"2","key":"204_CR78","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1128\/jvi.65.2.736-742.1991","volume":"65","author":"CA Jordan","year":"1991","unstructured":"Jordan CA, Watkins BA, Kufta C, Dubois-Dalcq M. Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. J Virol. 1991;65(2):736\u201342.","journal-title":"J Virol."},{"issue":"3","key":"204_CR79","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/glia.23081","volume":"65","author":"NC Chen","year":"2017","unstructured":"Chen NC, Partridge AT, Sell C, Torres C, Mart\u00edn-Garc\u00eda J. Fate of microglia during HIV-1 infection: from activation to senescence? Glia. 2017;65(3):431\u201346.","journal-title":"Glia."},{"issue":"1","key":"204_CR80","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1038\/s41598-017-12758-w","volume":"7","author":"P Castellano","year":"2017","unstructured":"Castellano P, Prevedel L, Eugenin EA. HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim. Sci Rep. 2017;7(1):12866.","journal-title":"Sci Rep."},{"issue":"2","key":"204_CR81","doi-asserted-by":"crossref","first-page":"e90620","DOI":"10.1371\/journal.pone.0090620","volume":"9","author":"LR Gray","year":"2014","unstructured":"Gray LR, Turville SG, HItchen TL, Cheng W-J, Ellett AM, Salimi H, et al. HIV-1 Entry and trans-infection of astrocytes involves CD81 vesicles. PLoS ONE. 2014;9(2):e90620.","journal-title":"PLoS ONE."},{"issue":"1","key":"204_CR82","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s13365-014-0304-0","volume":"21","author":"X Luo","year":"2015","unstructured":"Luo X, He JJ. Cell\u2013cell contact viral transfer contributes to HIV infection and persistence in astrocytes. J Neurovirol. 2015;21(1):66\u201380.","journal-title":"J Neurovirol."},{"issue":"5","key":"204_CR83","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/jnc.12443","volume":"127","author":"EA Eugenin","year":"2013","unstructured":"Eugenin EA, Berman JW. Cytochrome c dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP3 and calcium-dependent mechanism. J Neurochem. 2013;127(5):644\u201351.","journal-title":"J Neurochem"},{"issue":"11","key":"204_CR84","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/00005072-199911000-00005","volume":"58","author":"SF An","year":"1999","unstructured":"An SF, Groves M, Gray F, Scaravilli F. Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol. 1999;58(11):1156\u201362.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"204_CR85","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1046\/j.1365-2990.2003.00475.x","volume":"29","author":"CE Anderson","year":"2003","unstructured":"Anderson CE, Tomlinson GS, Pauly B, Brannan FW, Chiswick A, Brack-Werner R, et al. Relationship of Nef-positive and GFAP-reactive astrocytes to drug use in early and late HIV infection. Neuropathol Appl Neurobiol. 2003;29(4):378\u201388.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"204_CR86","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1750-3639.2003.tb00014.x","volume":"13","author":"G Trillo-Pazos","year":"2003","unstructured":"Trillo-Pazos G, Diamanturos A, Rislove L, Menza T, Chao W, Belem P, et al. Detection of HIV-1 DNA in microglia\/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol. 2003;13(2):144\u201354.","journal-title":"Brain Pathol."},{"key":"204_CR87","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.21697","volume":"66","author":"MJ Churchill","year":"2009","unstructured":"Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, et al. Extensive astrocyte infection is prominent in human immunodeficiency virus\u2014associated dementia. Ann Neurol. 2009;66:253\u20138.","journal-title":"Ann Neurol"},{"issue":"8","key":"204_CR88","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1128\/JVI.78.8.4120-4133.2004","volume":"78","author":"Y Liu","year":"2004","unstructured":"Liu Y, Liu H, Kim BO, Gattone VH, Li J, Nath A, et al. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol. 2004;78(8):4120\u201333.","journal-title":"J Virol"},{"issue":"17","key":"204_CR89","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.1128\/JVI.75.17.7925-7933.2001","volume":"75","author":"M Canki","year":"2001","unstructured":"Canki M, Thai JNF, Chao W, Ghorpade A, Potash MJ, Volsky DJ. Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes. J Virol. 2001;75(17):7925\u201333.","journal-title":"J Virol"},{"issue":"6","key":"204_CR90","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.celrep.2017.01.027","volume":"18","author":"RA Russell","year":"2017","unstructured":"Russell RA, Chojnacki J, Jones DM, Johnson E, Do T, Eggeling C, et al. Astrocytes resist HIV-1 fusion but engulf infected macrophage material. Cell Rep. 2017;18(6):1473\u201383.","journal-title":"Cell Rep."},{"key":"204_CR91","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11481-018-9809-2","volume":"14","author":"A Ko","year":"2018","unstructured":"Ko A, Kang G, Hattler JB, Galadima HI, Zhang J, Li Q, et al. Macrophages but not astrocytes harbor HIV DNA in the brains of HIV-1-infected aviremic individuals on suppressive antiretroviral therapy. J Neuroimmune Pharmacol. 2018;14:110\u20139.","journal-title":"J Neuroimmune Pharmacol."},{"issue":"2","key":"204_CR92","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.21697","volume":"66","author":"MJ Churchill","year":"2009","unstructured":"Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, et al. Extensive astrocyte infection is prominent in human immunodeficiency virus\u2014associated dementia. Ann Neurol. 2009;66(2):253\u20138.","journal-title":"Ann Neurol."},{"issue":"3","key":"204_CR93","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/brain\/awy339","volume":"142","author":"L Bertrand","year":"2019","unstructured":"Bertrand L, Cho HJ, Toborek M. Blood\u2013brain barrier pericytes as a target for HIV-1 infection. Brain. 2019;142(3):502\u201311.","journal-title":"Brain"},{"issue":"12","key":"204_CR94","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1111\/j.1582-4934.2012.01622.x","volume":"16","author":"S Nakagawa","year":"2012","unstructured":"Nakagawa S, Castro V, Toborek M. Infection of human pericytes by HIV-1 disrupts the integrity of the blood-brain barrier. J Cell Mol Med. 2012;16(12):2950\u20137.","journal-title":"J Cell Mol Med"},{"key":"204_CR95","first-page":"21","volume-title":"Handbook of clinical neurology","author":"B Sillman","year":"2018","unstructured":"Sillman B, Woldstad C, Mcmillan J, Gendelman HE. Neuropathogenesis of human immunodeficiency virus infection. Handbook of clinical neurology. Amsterdam: Elsevier; 2018. p. 21\u201340."},{"issue":"3","key":"204_CR96","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11481-010-9205-z","volume":"5","author":"KA Lindl","year":"2010","unstructured":"Lindl KA, Marks DR, Kolson DL, Jordan-Sciutto KL. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J Neuroimmune Pharmacol. 2010;5(3):294\u2013309.","journal-title":"J Neuroimmune Pharmacol."},{"key":"204_CR97","doi-asserted-by":"crossref","first-page":"8248","DOI":"10.1073\/pnas.91.17.8248","volume":"91","author":"A Mujeeb","year":"1994","unstructured":"Mujeeb A, Bishop K, Peterlintt BMM, Turck C, Parslowtllli TGG, James TLL. NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat (protein structure\/RNA-binding proteins\/gene regulation\/AIDS). Proc Natl Acad Sci USA. 1994;91:8248\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"204_CR98","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nsmb.3379","volume":"24","author":"A Hategan","year":"2017","unstructured":"Hategan A, Bianchet MA, Steiner J, Karnaukhova E, Masliah E, Fields A, et al. HIV Tat protein and amyloid-\u03b2 peptide form multifibrillar structures that cause neurotoxicity. Nat Struct Mol Biol. 2017;24(4):379\u201386.","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"204_CR99","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/13550289809114537","volume":"4","author":"AC Bratanich","year":"1998","unstructured":"Bratanich AC, Liu C, Mcarthur JC, Fudyk T, Glass JD, Mittoo S, et al. Brain-derived HIV-1 tat sequences from AIDS patients with dementia show increased molecular heterogeneity. J Neurovirol. 1998;4(4):387\u201393.","journal-title":"J Neurovirol."},{"issue":"2","key":"204_CR100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/13550280009013158","volume":"6","author":"L Hudson","year":"2000","unstructured":"Hudson L, Liu J, Nath A, Jones M, Raghavan R, Narayan O, et al. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol. 2000;6(2):145\u201355.","journal-title":"J Neurovirol."},{"issue":"13","key":"204_CR101","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1002\/j.1460-2075.1991.tb04997.x","volume":"10","author":"RA Marciniak","year":"1991","unstructured":"Marciniak RA, Sharp PA. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 1991;10(13):4189\u201396.","journal-title":"EMBO J"},{"issue":"36","key":"204_CR102","doi-asserted-by":"crossref","first-page":"22385","DOI":"10.1074\/jbc.272.36.22385","volume":"272","author":"P Chen","year":"1997","unstructured":"Chen P, Mayne M, Power C, Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-\u03b1 production. J Biol Chem. 1997;272(36):22385\u20138.","journal-title":"J Biol Chem"},{"issue":"2","key":"204_CR103","first-page":"111","volume":"27","author":"ZH Li","year":"2014","unstructured":"Li ZH, Pu SS, Gao WH, Chi YY, Wen HL, Wang ZY, Song YY, Yu XJ, et al. Effects of HIV-1 tat on secretion of TNF-(alpha) and IL-1(beta) by U87 cells in AIDS patients with or without AIDS dementia complex. Biomed Environ Sci. 2014;27(2):111\u20137.","journal-title":"Biomed Environ Sci"},{"issue":"15","key":"204_CR104","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1074\/jbc.M209381200","volume":"278","author":"A Chauhan","year":"2003","unstructured":"Chauhan A, Turchan J, Pocernich C, Bruce-Keller A, Roth S, Butterfield DA, et al. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J Biol Chem. 2003;278(15):13512\u20139.","journal-title":"J Biol Chem"},{"issue":"2","key":"204_CR105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.expneurol.2011.03.006","volume":"229","author":"EO Lee","year":"2011","unstructured":"Lee EO, Kim SE, Park HK, Kang JL, Chong YH. Extracellular HIV-1 Tat upregulates TNF-\u03b1 dependent MCP-1\/CCL2 production via activation of ERK1\/2 pathway in rat hippocampal slice cultures: inhibition by resveratrol, a polyphenolic phytostilbene. Exp Neurol. 2011;229(2):399\u2013408.","journal-title":"Exp Neurol"},{"issue":"9","key":"204_CR106","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/jnr.23051","volume":"90","author":"SE Kim","year":"2012","unstructured":"Kim SE, Lee EO, Yang JH, Kang JHL, Suh YH, Chong YH. 15-deoxy-\u039412,14-prostaglandin J2inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1\/CCL2 production by blocking the extracellular signal-regulated kinase-1\/2 signaling pathway independently of peroxisome proliferator-act. J Neurosci Res. 2012;90(9):1732\u201342.","journal-title":"J Neurosci Res"},{"issue":"1\u20132","key":"204_CR107","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-5728(98)00044-7","volume":"87","author":"BE Sawaya","year":"1998","unstructured":"Sawaya BE, Thatikunta P, Denisova L, Brady J, Khalili K, Amini S. Regulation of TNF\u03b1 and TGF\u03b2-1 gene transcription by HIV-1 Tat in CNS cells. J Neuroimmunol. 1998;87(1\u20132):33\u201342.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"204_CR108","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.micinf.2005.11.014","volume":"8","author":"JE King","year":"2006","unstructured":"King JE, Eugenin EA, Buckner CM, Berman JW. HIV tat and neurotoxicity. Microbes Infect. 2006;8(5):1347\u201357.","journal-title":"Microbes Infect"},{"issue":"24","key":"204_CR109","doi-asserted-by":"crossref","first-page":"17098","DOI":"10.1074\/jbc.274.24.17098","volume":"274","author":"A Nath","year":"1999","unstructured":"Nath A, Conant K, Chen P, Scott C, Major EO. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. J Biol Chem. 1999;274(24):17098\u2013102.","journal-title":"J Biol Chem"},{"issue":"6","key":"204_CR110","first-page":"3117","volume":"95","author":"K Conant","year":"1998","unstructured":"Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Med Sci. 1998;95(6):3117\u201321.","journal-title":"Med Sci."},{"issue":"43","key":"204_CR111","doi-asserted-by":"crossref","first-page":"22830","DOI":"10.1074\/jbc.M116.731836","volume":"291","author":"Y Fan","year":"2016","unstructured":"Fan Y, He JJ. HIV-1 tat promotes lysosomal exocytosis in astrocytes and contributes to astrocyte-mediated Tat neurotoxicity. J Biol Chem. 2016;291(43):22830\u201340.","journal-title":"J Biol Chem"},{"issue":"3","key":"204_CR112","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.mcn.2004.07.003","volume":"27","author":"BY Zhou","year":"2004","unstructured":"Zhou BY, Liu Y, Oh Kim B, Xiao Y, He J. Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes. Mol Cell Neurosci. 2004;27(3):296\u2013305.","journal-title":"Mol Cell Neurosci."},{"issue":"10","key":"204_CR113","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/jcp.22609","volume":"226","author":"K Kim","year":"2011","unstructured":"Kim K, Lee S-G, Kegelman TP, Su Z-Z, Das SK, Dash R, et al. Role of Excitatory Amino Acid Transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol. 2011;226(10):2484\u201393.","journal-title":"J Cell Physiol"},{"issue":"7","key":"204_CR114","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2174\/157016211798842116","volume":"9","author":"A Landi","year":"2011","unstructured":"Landi A, Iannucci V, Van Nuffel A, Meuwissen P, Verhasselt B. One protein to rule them all: modulation of cell surface receptors and molecules by HIV Nef. Curr HIV Res. 2011;9(7):496\u2013504.","journal-title":"Curr HIV Res"},{"issue":"1","key":"204_CR115","doi-asserted-by":"crossref","first-page":"e2542","DOI":"10.1038\/cddis.2016.467","volume":"8","author":"A Sami Saribas","year":"2017","unstructured":"Sami Saribas A, Cicalese S, Ahooyi TM, Khalili K, Amini S, Sariyer IK. HIV-1 Nef is released in extracellular vesicles derived from astrocytes: evidence for Nef-mediated neurotoxicity. Cell Death Dis. 2017;8(1):e2542.","journal-title":"Cell Death Dis."},{"key":"204_CR116","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbi.2014.02.016","volume":"40","author":"S Acharjee","year":"2014","unstructured":"Acharjee S, Branton WG, Vivithanaporn P, Maingat F, Paul AM, Dickie P, et al. HIV-1 Nef expression in microglia disrupts dopaminergic and immune functions with associated mania-like behaviors. Brain Behav Immun. 2014;40:74\u201384.","journal-title":"Brain Behav Immun"},{"issue":"11","key":"204_CR117","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nbd.2012.08.007","volume":"49","author":"G Chompre","year":"2013","unstructured":"Chompre G, Cruz E, Maldonado L, Rivera-Amill V, Porter JT, Noel RJ. Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory. Neurobiol Dis. 2013;49(11):128\u201336.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"204_CR118","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12974-017-0957-8","volume":"14","author":"A Omeragic","year":"2017","unstructured":"Omeragic A, Hoque MT, Choi U, Bendayan R. Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation. J Neuroinflamm. 2017;14(1):183.","journal-title":"J Neuroinflamm"},{"issue":"3","key":"204_CR119","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1124\/mol.106.025973","volume":"70","author":"PT Ronaldson","year":"2006","unstructured":"Ronaldson PT, Bendayan R. HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein. Mol Pharmacol. 2006;70(3):1087\u201398.","journal-title":"Mol Pharmacol"},{"issue":"11","key":"204_CR120","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/jnr.22720","volume":"89","author":"T Ashraf","year":"2011","unstructured":"Ashraf T, Ronaldson PT, Persidsky Y, Bendayan R. Regulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes. J Neurosci Res. 2011;89(11):1773\u201382.","journal-title":"J Neurosci Res"},{"issue":"4","key":"204_CR121","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s12640-016-9608-6","volume":"29","author":"V Avdoshina","year":"2016","unstructured":"Avdoshina V, Fields JA, Castellano P, Dedoni S, Palchik G, Trejo M, et al. The HIV protein gp120 alters mitochondrial dynamics in neurons. Neurotox Res. 2016;29(4):583\u201393.","journal-title":"Neurotox Res"},{"issue":"2","key":"204_CR122","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1531-8249(200002)47:2<186::AID-ANA8>3.0.CO;2-3","volume":"47","author":"A Nath","year":"2000","unstructured":"Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol. 2000;47(2):186\u201394.","journal-title":"Ann Neurol"},{"issue":"17","key":"204_CR123","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1097\/00002030-200012010-00010","volume":"14","author":"MV Jones","year":"2000","unstructured":"Jones MV, Bell JE, Nath A. Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia. AIDS. 2000;14(17):2709\u201313.","journal-title":"AIDS."},{"issue":"3","key":"204_CR124","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.nbd.2009.03.003","volume":"34","author":"J-P Louboutin","year":"2009","unstructured":"Louboutin J-P, Agrawal L, Reyes BAS, Van Bockstaele EJ, Strayer DS. HIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: protection by rSV40 delivery of antioxidant enzymes. Neurobiol Dis. 2009;34(3):462\u201376.","journal-title":"Neurobiol Dis"},{"key":"204_CR125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2009.09.113","volume":"1306","author":"L Agrawal","year":"2010","unstructured":"Agrawal L, Louboutin J-P, Marusich E, Reyes BAS, Van Bockstaele EJ, Strayer DS. Dopaminergic neurotoxicity of HIV-1 gp120: reactive oxygen species as signaling intermediates. Brain Res. 2010;1306:116\u201330.","journal-title":"Brain Res"},{"issue":"6A","key":"204_CR126","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1582-4934.2008.00402.x","volume":"12","author":"AM Gorman","year":"2008","unstructured":"Gorman AM. Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling: Apoptosis Review Series. J Cell Mol Med. 2008;12(6A):2263\u201380.","journal-title":"J Cell Mol Med"},{"issue":"50","key":"204_CR127","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1038\/onc.2008.308","volume":"27","author":"P Pinton","year":"2008","unstructured":"Pinton P, Giorgi C, Siviero R, Zecchini E, Rizzuto R. Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene. 2008;27(50):6407\u201318.","journal-title":"Oncogene"},{"issue":"10","key":"204_CR128","doi-asserted-by":"crossref","first-page":"e25994","DOI":"10.1371\/journal.pone.0025994","volume":"6","author":"L Chen","year":"2011","unstructured":"Chen L, Liu J, Xu C, Keblesh J, Zang W, Xiong H. HIV-1gp120 induces neuronal apoptosis through enhancement of 4-aminopyridine-senstive outward K + currents. PLoS ONE. 2011;6(10):e25994.","journal-title":"PLoS ONE."},{"issue":"1","key":"204_CR129","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0042-6822(03)00181-8","volume":"312","author":"Z Wang","year":"2003","unstructured":"Wang Z, Pekarskaya O, Bencheikh M, Chao W, Gelbard HA, Ghorpade A, et al. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology. 2003;312(1):60\u201373.","journal-title":"Virology"},{"issue":"3","key":"204_CR130","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s13365-015-0403-6","volume":"22","author":"RII Melendez","year":"2016","unstructured":"Melendez RII, Roman C, Capo-Velez CMM, Lasalde-Dominicci JAA. Decreased glial and synaptic glutamate uptake in the striatum of HIV-1 gp120 transgenic mice. J Neurovirol. 2016;22(3):358\u201365.","journal-title":"J Neurovirol."},{"issue":"1","key":"204_CR131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.jcbfm.9600330","volume":"27","author":"GD Kanmogne","year":"2007","unstructured":"Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y. HIV-1 gp120 compromises blood-brain barrier integrity and enhance monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab. 2007;27(1):123\u201334.","journal-title":"J Cereb Blood Flow Metab"},{"key":"204_CR132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1100\/2012\/482575","volume":"2012","author":"J-P Louboutin","year":"2012","unstructured":"Louboutin J-P, Strayer DS. Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications. Sci World J. 2012;2012:1\u201315.","journal-title":"Sci World J"},{"issue":"1\u20132","key":"204_CR133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2009.03.013","volume":"85","author":"H Tang","year":"2009","unstructured":"Tang H, Lu D, Pan R, Qin X, Xiong H, Dong J. Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats. Life Sci. 2009;85(1\u20132):1\u201310.","journal-title":"Life Sci"},{"issue":"1\u20132","key":"204_CR134","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-8993(92)90562-N","volume":"570","author":"JR Glowa","year":"1992","unstructured":"Glowa JR, Panlilio LV, Brenneman DE, Gozes I, Fridkin M, Hill JM. Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res. 1992;570(1\u20132):49\u201353.","journal-title":"Brain Res"},{"issue":"6","key":"204_CR135","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0889-1591(02)00025-9","volume":"16","author":"O Barak","year":"2002","unstructured":"Barak O, Weidenfeld J, Goshen I, Ben-Hur T, Taylor AN, Yirmiya R. Intracerebral HIV-1 glycoprotein 120 produces sickness behavior and pituitary\u2013adrenal activation in rats: role of prostaglandins. Brain Behav Immun. 2002;16(6):720\u201335.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"204_CR136","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0006-8993(02)02280-1","volume":"933","author":"O Barak","year":"2002","unstructured":"Barak O, Goshen I, Ben-Hur T, Weidenfeld J, Taylor AN, Yirmiya R. Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120. Brain Res. 2002;933(2):98\u2013108.","journal-title":"Brain Res"},{"issue":"4","key":"204_CR137","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s13365-016-0436-5","volume":"22","author":"T James","year":"2016","unstructured":"James T, Nonnemacher MR, Wigdahl B, Krebs FC. Defining the roles for Vpr in HIV-1-associated neuropathogenesis. J Neurovirol. 2016;22(4):403\u201315.","journal-title":"J Neurovirol."},{"issue":"3","key":"204_CR138","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/13550280600827377","volume":"12","author":"E DA Wheeler","year":"2006","unstructured":"DA Wheeler E, Achim CL, Ayyavoo V. Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients. J Neurovirol. 2006;12(3):200\u201310.","journal-title":"J Neurovirol."},{"issue":"14","key":"204_CR139","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1523\/JNEUROSCI.5522-06.2007","volume":"27","author":"GJ Jones","year":"2007","unstructured":"Jones GJ, Barsby NL, Cohen EA, Holden J, Harris K, Dickie P, et al. HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration. J Neurosci. 2007;27(14):3703\u201311.","journal-title":"J Neurosci"},{"key":"204_CR140","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2017.02.008","volume":"117","author":"Y Wang","year":"2017","unstructured":"Wang Y, Santerre M, Tempera I, Martin K, Mukerjee R, Sawaya BE. HIV-1 Vpr disrupts mitochondria axonal transport and accelerates neuronal aging. Neuropharmacology. 2017;117:364\u201375.","journal-title":"Neuropharmacology"},{"key":"204_CR141","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2009.03.024","volume":"1275","author":"I Rom","year":"2009","unstructured":"Rom I, Deshmane SL, Mukerjee R, Khalili K, Amini S, Sawaya BE. HIV-1 Vpr deregulates calcium secretion in neural cells. Brain Res. 2009;1275:81\u20136.","journal-title":"Brain Res"},{"issue":"1","key":"204_CR142","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/1742-2094-9-138","volume":"9","author":"D Guha","year":"2012","unstructured":"Guha D, Nagilla P, Redinger C, Srinivasan A, Schatten GP, Ayyavoo V. Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells. J Neuroinflammation. 2012;9(1):664.","journal-title":"J Neuroinflammation."},{"issue":"10","key":"204_CR143","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/QAD.0b013e32835521a3","volume":"26","author":"S Vella","year":"2012","unstructured":"Vella S, Schwartl\u00e4nder B, Sow SP, Eholie SP, Murphy RL. The history of antiretroviral therapy and of its implementation in resource-limited areas of the world. AIDS. 2012;26(10):1231\u201341.","journal-title":"AIDS."},{"issue":"1","key":"204_CR144","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","volume":"65","author":"S Letendre","year":"2008","unstructured":"Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, et al. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008;65(1):65\u201370.","journal-title":"Arch Neurol"},{"issue":"3","key":"204_CR145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s13365-015-0404-5","volume":"22","author":"A Carvalhal","year":"2016","unstructured":"Carvalhal A, Gill MJ, Letendre SL, Rachlis A, Bekele T, Raboud J, et al. Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study. J Neurovirol. 2016;22(3):349\u201357.","journal-title":"J Neurovirol."},{"issue":"1","key":"204_CR146","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1038\/s41467-019-10046-x","volume":"10","author":"L Bertrand","year":"2019","unstructured":"Bertrand L, M\u00e9roth F, Tournebize M, Leda AR, Sun E, Toborek M. Targeting the HIV-infected brain to improve ischemic stroke outcome. Nat Commun. 2019;10(1):2009.","journal-title":"Nat Commun."},{"issue":"5","key":"204_CR147","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s13365-012-0120-3","volume":"18","author":"K Robertson","year":"2012","unstructured":"Robertson K, Liner J, Meeker RB. Antiretroviral neurotoxicity. J Neurovirol. 2012;18(5):388\u201399.","journal-title":"J Neurovirol."},{"key":"204_CR148","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","volume":"76","author":"N Ciccarelli","year":"2011","unstructured":"Ciccarelli N, Fabbiani M, Baldonero E. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV- infected patients. Neurology. 2011;76:1403\u20139.","journal-title":"Neurology."},{"issue":"2","key":"204_CR149","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s13365-015-0382-7","volume":"22","author":"Q Ma","year":"2016","unstructured":"Ma Q, Vaida F, Wong J, Sanders CA, Kao Y-T, Croteau D, et al. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol. 2016;22(2):170\u20138.","journal-title":"J Neurovirol."},{"key":"204_CR150","first-page":"199","volume-title":"Expression and function of P-glycoprotein in normal tissues: effect on pharmacokinetics","author":"F Staud","year":"2010","unstructured":"Staud F, Ceckova M, Micuda S, Pavek P. Expression and function of P-glycoprotein in normal tissues: effect on pharmacokinetics. Totowa: Humana Press; 2010. p. 199\u2013222."},{"issue":"9","key":"204_CR151","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1128\/AAC.00486-13","volume":"57","author":"GNY Chan","year":"2013","unstructured":"Chan GNY, Patel R, Cummins CL, Bendayan R. Induction of P-glycoprotein by antiretroviral drugs in human brain microvessel endothelial cells. Antimicrob Agents Chemother. 2013;57(9):4481\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"204_CR152","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tips.2013.05.004","volume":"34","author":"GNY Chan","year":"2013","unstructured":"Chan GNY, Hoque MT, Bendayan R. Role of nuclear receptors in the regulation of drug transporters in the brain. Trends Pharmacol Sci. 2013;34:361\u201372.","journal-title":"Trends Pharmacol Sci."},{"issue":"4","key":"204_CR153","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/QAI.0b013e318247ec54","volume":"59","author":"BM Best","year":"2012","unstructured":"Best BM, Letendre SL, Koopmans P, Rossi SS, Clifford DB, Collier AC, et al. Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. JAIDS J Acquir Immune Defic Syndr. 2012;59(4):376\u201381.","journal-title":"JAIDS J Acquir Immune Defic Syndr."},{"issue":"1","key":"204_CR154","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/QAD.0b013e328317a702","volume":"23","author":"BM Best","year":"2009","unstructured":"Best BM, Letendre SL, Brigid E, Clifford DB, Collier AC, Gelman BB, et al. Low atazanavir concentrations in cerebrospinal fluid. AIDS. 2009;23(1):83\u20137.","journal-title":"AIDS."},{"issue":"11","key":"204_CR155","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/00002030-200007280-00014","volume":"14","author":"EH Gisolf","year":"2000","unstructured":"Gisolf EH, Enting RH, Jurriaans S, de Wolf F, van der Ende ME, Hoetelmans RMW, et al. Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir\/saquinavir or ritonavir\/saquinavir\/stavudine. AIDS. 2000;14(11):1583\u20139.","journal-title":"AIDS."},{"issue":"1","key":"204_CR156","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1038\/s41598-020-60684-1","volume":"10","author":"Y Gong","year":"2020","unstructured":"Gong Y, Chowdhury P, Nagesh PKB, Rahman MA, Zhi K, Yallapu MM, et al. Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages. Sci Rep. 2020;10(1):3835.","journal-title":"Sci Rep."},{"issue":"5","key":"204_CR157","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1021\/acs.jmedchem.9b00779","volume":"63","author":"N Agrawal","year":"2020","unstructured":"Agrawal N, Rowe J, Lan J, Yu Q, Hrycyna CA, Chmielewski J. Potential tools for eradicating HIV reservoirs in the brain: development of trojan horse prodrugs for the inhibition of P-glycoprotein with anti-HIV-1 activity. J Med Chem. 2020;63(5):2131\u20138.","journal-title":"J Med Chem"},{"issue":"1","key":"204_CR158","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1038\/s41598-019-40222-4","volume":"9","author":"A Kaushik","year":"2019","unstructured":"Kaushik A, Yndart A, Atluri V, Tiwari S, Tomitaka A, Gupta P, et al. Magnetically guided non-invasive CRISPR-Cas9\/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection. Sci Rep. 2019;9(1):3928.","journal-title":"Sci Rep."},{"issue":"2","key":"204_CR159","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2011.08.001","volume":"161","author":"BM Friedrich","year":"2011","unstructured":"Friedrich BM, Dziuba N, Li G, Endsley MA, Murray JL, Ferguson MR. Host factors mediating HIV-1 replication. Virus Res. 2011;161(2):101\u201314.","journal-title":"Virus Res"},{"issue":"1","key":"204_CR160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13365-016-0472-1","volume":"23","author":"P Rawat","year":"2017","unstructured":"Rawat P, Spector SA. Development and characterization of a human microglia cell model of HIV-1 infection. J Neurovirol. 2017;23(1):33\u201346.","journal-title":"J Neurovirol."},{"issue":"3","key":"204_CR161","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tins.2011.12.006","volume":"35","author":"S Gorantla","year":"2012","unstructured":"Gorantla S, Poluektova L, Gendelman HE. Rodent models for HIV-associated neurocognitive disorders. Trends Neurosci. 2012;35(3):197\u2013208.","journal-title":"Trends Neurosci"},{"issue":"12","key":"204_CR162","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nrmicro2911","volume":"10","author":"T Hatziioannou","year":"2012","unstructured":"Hatziioannou T, Evans DT. Animal models for HIV\/AIDS research. Nat Rev Microbiol. 2012;10(12):852\u201367.","journal-title":"Nat Rev Microbiol"},{"issue":"26","key":"204_CR163","doi-asserted-by":"crossref","first-page":"14637","DOI":"10.1073\/pnas.94.26.14637","volume":"94","author":"J Browning","year":"1997","unstructured":"Browning J, Horner JW, Pettoello-Mantovani M, Raker C, Yurasov S, DePinho RA, et al. Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc Natl Acad Sci. 1997;94(26):14637\u201341.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"204_CR164","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1099\/0022-1317-76-6-1327","volume":"76","author":"CS Dunn","year":"1995","unstructured":"Dunn CS, Mehtali M, Houdebine LM, Gut J-P, Kirn A, Aubertin A-M. Human immunodeficiency virus type 1 infection of human CD4-transgenic rabbits. J Gen Virol. 1995;76(6):1327\u201336.","journal-title":"J Gen Virol"},{"issue":"6","key":"204_CR165","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1084\/jem.20011549","volume":"195","author":"OT Keppler","year":"2002","unstructured":"Keppler OT, Welte FJ, Ngo TA, Chin PS, Patton KS, Tsou C-L, et al. Progress toward a human CD4\/CCR5 transgenic rat model for De Novo infection by human immunodeficiency virus type 1. J Exp Med. 2002;195(6):719\u201336.","journal-title":"J Exp Med"},{"issue":"6459","key":"204_CR166","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/367188a0","volume":"367","author":"SM Toggas","year":"1994","unstructured":"Toggas SM, Masliah E, Rockenstein EM, Rail GF, Abraham CR, Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice. Nature. 1994;367(6459):188\u201393.","journal-title":"Nature"},{"issue":"10","key":"204_CR167","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1523\/JNEUROSCI.22-10-04015.2002","volume":"22","author":"GA Garden","year":"2002","unstructured":"Garden GA, Budd SL, Tsai E, Hanson L, Kaul M, D\u2019Emilia DM, et al. Caspase cascades in human immunodeficiency virus-associated neurodegeneration. J Neurosci. 2002;22(10):4015\u201324.","journal-title":"J Neurosci"},{"issue":"17","key":"204_CR168","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1097\/00002030-199912030-00005","volume":"13","author":"S Toneatto","year":"1999","unstructured":"Toneatto S, Finco O, Van Der Putten H, Abrignani S, Annunziata P. Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice. Aids. 1999;13(17):2343\u20138.","journal-title":"Aids."},{"issue":"5","key":"204_CR169","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0002-9440(10)64304-0","volume":"162","author":"BO Kim","year":"2003","unstructured":"Kim BO, Liu Y, Ruan Y, Xu ZC, Schantz L, He JJ. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol. 2003;162(5):1693\u2013707.","journal-title":"Am J Pathol"},{"issue":"11","key":"204_CR170","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1096\/fj.10-162313","volume":"24","author":"S Acharjee","year":"2010","unstructured":"Acharjee S, Noorbakhsh F, Stemkowski PL, Olechowski C, Cohen \u00c9A, Ballanyi K, et al. HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain. FASEB J. 2010;24(11):4343\u201353.","journal-title":"FASEB J."},{"issue":"2","key":"204_CR171","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11481-011-9310-7","volume":"7","author":"C Power","year":"2012","unstructured":"Power C, Hui E, Vivithanaporn P, Acharjee S, Polyak M. Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr. J Neuroimmune Pharmacol. 2012;7(2):319\u201331.","journal-title":"J Neuroimmune Pharmacol."},{"issue":"16","key":"204_CR172","doi-asserted-by":"crossref","first-page":"9271","DOI":"10.1073\/pnas.161290298","volume":"98","author":"W Reid","year":"2001","unstructured":"Reid W, Sadowska M, Denaro F, Rao S, Foulke J, Hayes N, et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci. 2001;98(16):9271\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"204_CR173","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbi.2015.02.020","volume":"48","author":"M Vigorito","year":"2015","unstructured":"Vigorito M, Connaghan KP, Chang SL. The HIV-1 transgenic rat model of neuroHIV. Brain Behav Immun. 2015;48:336\u201349.","journal-title":"Brain Behav Immun"},{"key":"204_CR174","doi-asserted-by":"crossref","unstructured":"Potash MJ, Chao W, Bentsman G, Paris N, Saini M, Nitkiewicz J, et al. A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness EcoHIV infection of mice forms a useful model of HIV-1 infection of human beings for convenient and safe investigation of HIV-1 therapy, vaccines; 2005.","DOI":"10.1073\/pnas.0500649102"},{"key":"204_CR175","first-page":"1","volume":"14","author":"CJ Gu","year":"2018","unstructured":"Gu CJ, Borjabad A, Hadas E, Kelschenbach J, Kim BH, Chao W, et al. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. PLoS Pathog. 2018;14:1\u201333.","journal-title":"PLoS Pathog"},{"issue":"4","key":"204_CR176","doi-asserted-by":"crossref","first-page":"L500","DOI":"10.1152\/ajplung.00431.2016","volume":"312","author":"P Geraghty","year":"2017","unstructured":"Geraghty P, Hadas E, Kim B-H, Dabo AJ, Volsky DJ, Foronjy R. HIV infection model of chronic obstructive pulmonary disease in mice. Am J Physiol Lung Cell Mol Physiol. 2017;312(4):L500\u20139.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"issue":"1","key":"204_CR177","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/NEN.0000000000000026","volume":"73","author":"H He","year":"2014","unstructured":"He H, Sharer LR, Chao W, Gu CJJ, Borjabad A, Hadas E, et al. Enhanced human immunodeficiency virus Type 1 expression and neuropathogenesis in knockout mice lacking Type I interferon responses. J Neuropathol Exp Neurol. 2014;73(1):59\u201371.","journal-title":"J Neuropathol Exp Neurol."},{"issue":"1","key":"204_CR178","doi-asserted-by":"crossref","first-page":"9428","DOI":"10.1038\/s41598-019-45878-6","volume":"9","author":"A Omeragic","year":"2019","unstructured":"Omeragic A, Kara-Yacoubian N, Kelschenbach J, Sahin C, Cummins CL, Volsky DJ, et al. Peroxisome proliferator-activated receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model. Sci Rep. 2019;9(1):9428.","journal-title":"Sci Rep."},{"issue":"4","key":"204_CR179","first-page":"1","volume":"10","author":"J Kelschenbach","year":"2019","unstructured":"Kelschenbach J, He H, Kim B, Borjabad A, Gu C, Chao W, et al. Efficient expression of HIV in immunocompetent mouse brain reveals a novel nonneurotoxic viral function in hippocampal synaptodendritic injury and memory impairment. Am Soc Microbiol. 2019;10(4):1\u201317.","journal-title":"Am Soc Microbiol."},{"issue":"16","key":"204_CR180","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.1021\/acs.jmedchem.7b00966","volume":"60","author":"MT Nedelcovych","year":"2017","unstructured":"Nedelcovych MT, Tenora L, Kim BH, Kelschenbach J, Chao W, Hadas E, et al. N-(Pivaloyloxy)alkoxy-carbonyl prodrugs of the glutamine antagonist 6-diazo-5-oxo-l-norleucine (DON) as a potential treatment for HIV associated neurocognitive disorders. J Med Chem. 2017;60(16):7136\u201398.","journal-title":"J Med Chem"},{"key":"204_CR181","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11481-019-09859-w","volume":"14","author":"MT Nedelcovych","year":"2019","unstructured":"Nedelcovych MT, Kim B-H, Zhu X, Lovell LE, Manning AA, Kelschenbach J, et al. Glutamine antagonist JHU083 normalizes aberrant glutamate production and cognitive deficits in the EcoHIV murine model of HIV-associated neurocognitive disorders. J Neuroimmune Pharmacol. 2019;14:391\u2013400.","journal-title":"J Neuroimmune Pharmacol."},{"issue":"6","key":"204_CR182","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/QAD.0000000000002150","volume":"33","author":"BH Kim","year":"2019","unstructured":"Kim BH, Kelschenbach J, Borjabad A, Hadas E, He H, Potash MJ, et al. Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice. AIDS. 2019;33(6):973\u201384.","journal-title":"AIDS."},{"issue":"19","key":"204_CR183","doi-asserted-by":"crossref","first-page":"10285","DOI":"10.1073\/pnas.93.19.10285","volume":"93","author":"T Blunt","year":"1996","unstructured":"Blunt T, Gell D, Fox M, Taccioli GE, Lehmann AR, Jackson SP, et al. Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc Natl Acad Sci. 1996;93(19):10285\u201390.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"204_CR184","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00042560-199805010-00003","volume":"18","author":"N Avgeropoulos","year":"1998","unstructured":"Avgeropoulos N, Kelley B, Middaugh L, Arrigo S, Persidsky Y, Gendelman HE, et al. SCID mice with HIV encephalitis develop behavioral abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(1):13\u201320.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"2","key":"204_CR185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0306-4522(02)00925-9","volume":"118","author":"E Anderson","year":"2003","unstructured":"Anderson E, Boyle J, Zink W, Persidsky Y, Gendelman H, Xiong H. Hippocampal synaptic dysfunction in a murine model of human immunodeficiency virus type 1 encephalitis. Neuroscience. 2003;118(2):359\u201369.","journal-title":"Neuroscience"},{"issue":"5","key":"204_CR186","first-page":"S14","volume":"6 Suppl 1","author":"H Xiong","year":"2000","unstructured":"Xiong H, Zeng YC, Lewis T, Zheng J, Persidsky Y, Gendelman HE. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. J Neurovirol. 2000;6 Suppl 1(5):S14\u201323.","journal-title":"J Neurovirol."},{"issue":"12","key":"204_CR187","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1523\/JNEUROSCI.5595-08.2009","volume":"29","author":"AR Sas","year":"2009","unstructured":"Sas AR, Bimonte-Nelson H, Smothers CT, Woodward J, Tyor WR. Interferon-\u03b1 causes neuronal dysfunction in encephalitis. J Neurosci. 2009;29(12):3948\u201355.","journal-title":"J Neurosci"},{"issue":"12","key":"204_CR188","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.4049\/jimmunol.172.12.7610","volume":"172","author":"L Poluektova","year":"2004","unstructured":"Poluektova L, Gorantla S, Faraci J, Birusingh K, Dou H, Gendelman HE. Neuroregulatory events follow adaptive immune-mediated elimination of HIV-1-infected macrophages: studies in a murine model of viral encephalitis. J Immunol. 2004;172(12):7610\u20137.","journal-title":"J Immunol."},{"issue":"8","key":"204_CR189","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.4049\/jimmunol.168.8.3941","volume":"168","author":"LY Poluektova","year":"2002","unstructured":"Poluektova LY, Munn DH, Persidsky Y, Gendelman HE. Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J Immunol. 2002;168(8):3941\u20139.","journal-title":"J Immunol."},{"issue":"9","key":"204_CR190","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD\/SCID\/gamma cnull mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100(9):3175\u201382.","journal-title":"Blood"},{"issue":"5","key":"204_CR191","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2005-02-0516","volume":"106","author":"F Ishikawa","year":"2005","unstructured":"Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, et al. Development of functional human blood and immune systems in NOD\/SCID\/IL2 receptor chainnull mice. Blood. 2005;106(5):1565\u201373.","journal-title":"Blood"},{"issue":"10","key":"204_CR192","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","volume":"174","author":"LD Shultz","year":"2005","unstructured":"Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, et al. Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R null mice engrafted with mobilized human hemopoietic stem cells. J Immunol. 2005;174(10):6477\u201389.","journal-title":"J Immunol."},{"issue":"1","key":"204_CR193","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clim.2009.12.008","volume":"135","author":"MA Brehm","year":"2010","unstructured":"Brehm MA, Cuthbert A, Yang C, Miller DM, DiIorio P, Laning J, et al. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2r\u03b3null mutation. Clin Immunol. 2010;135(1):84\u201398.","journal-title":"Clin Immunol."},{"issue":"9","key":"204_CR194","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1523\/JNEUROSCI.5473-10.2011","volume":"31","author":"PK Dash","year":"2011","unstructured":"Dash PK, Gorantla S, Gendelman HE, Knibbe J, Casale GP, Makarov E, et al. Loss of neuronal integrity during progressive HIV-1 infection of humanized mice. J Neurosci. 2011;31(9):3148\u201357.","journal-title":"J Neurosci"},{"issue":"6","key":"204_CR195","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.2353\/ajpath.2010.100536","volume":"177","author":"S Gorantla","year":"2010","unstructured":"Gorantla S, Makarov E, Finke-Dwyer J, Castanedo A, Holguin A, Gebhart CL, et al. Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis. Am J Pathol. 2010;177(6):2938\u201349.","journal-title":"Am J Pathol"},{"issue":"11","key":"204_CR196","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nm1431","volume":"12","author":"MW Melkus","year":"2006","unstructured":"Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, Othieno FA, et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med. 2006;12(11):1316\u201322.","journal-title":"Nat Med"},{"key":"204_CR197","first-page":"149","volume-title":"Current topics microbiology immunology","author":"AK Wege","year":"2008","unstructured":"Wege AK, Melkus MW, Denton PW, Estes JD, Garcia JV. Functional and phenotypic characterization of the humanized BLT mouse model. Current topics microbiology immunology. Berlin: Springer; 2008. p. 149\u201365."},{"issue":"1","key":"204_CR198","doi-asserted-by":"crossref","first-page":"23513","DOI":"10.1038\/srep23513","volume":"6","author":"M Ara\u00ednga","year":"2016","unstructured":"Ara\u00ednga M, Su H, Poluektova LY, Gorantla S, Gendelman HE. HIV-1 cellular and tissue replication patterns in infected humanized mice. Sci Rep. 2016;6(1):23513.","journal-title":"Sci Rep."},{"issue":"1","key":"204_CR199","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12977-017-0370-5","volume":"14","author":"EL Asahchop","year":"2017","unstructured":"Asahchop EL, Meziane O, Mamik MK, Chan WF, Branton WG, Resch L, et al. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain. Retrovirology. 2017;14(1):47.","journal-title":"Retrovirology."},{"issue":"3","key":"204_CR200","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s13365-014-0299-6","volume":"21","author":"JB Honeycutt","year":"2015","unstructured":"Honeycutt JB, Sheridan PA, Matsushima GK, Garcia JV. Humanized mouse models for HIV-1 infection of the CNS. J Neurovirol. 2015;21(3):301\u20139.","journal-title":"J Neurovirol."},{"issue":"6073","key":"204_CR201","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1126\/science.1217550","volume":"335","author":"A Chahroudi","year":"2012","unstructured":"Chahroudi A, Bosinger SE, Vanderford TH, Paiardini M, Silvestri G. Natural SIV Hosts: Showing AIDS the Door. Science (80-). 2012;335(6073):1188\u201393.","journal-title":"Science (80-)"},{"issue":"4","key":"204_CR202","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/13550280802132832","volume":"14","author":"JE Clements","year":"2008","unstructured":"Clements JE, Mankowski JL, Gama L, Zink MC. The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus\u2013associated neurological disease: from mechanism to treatment. J Neurovirol. 2008;14(4):309\u201317.","journal-title":"J Neurovirol."},{"issue":"8","key":"204_CR203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1371\/journal.ppat.1001064","volume":"6","author":"NE Riddick","year":"2010","unstructured":"Riddick NE, Hermann EA, Loftin LM, Elliott ST, Wey WC, Cervasi B, et al. A novel CCR5 mutation common in sooty mangabeys reveals sivsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo. PLoS Pathog. 2010;6(8):71\u20132.","journal-title":"PLoS Pathog"},{"issue":"4790","key":"204_CR204","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1126\/science.3643650","volume":"235","author":"N Pedersen","year":"1987","unstructured":"Pedersen N, Ho E, Brown M, Yamamoto J. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science (80-). 1987;235(4790):790\u20133.","journal-title":"Science (80-)"},{"issue":"5","key":"204_CR205","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1128\/jvi.65.5.2225-2230.1991","volume":"65","author":"M Torten","year":"1991","unstructured":"Torten M, Franchini M, Barlough JE, George JW, Mozes E, Lutz H, et al. Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J Virol. 1991;65(5):2225\u201330.","journal-title":"J Virol"},{"key":"204_CR206","first-page":"658","volume":"3","author":"SW Dow","year":"1990","unstructured":"Dow SW, Poss ML, Hoover EA. Feline immunodeficiency virus: a neurotropic lentivirus. J Acquir Immune Defic Syndr. 1990;3:658\u201368.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"204_CR207","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/026988110001400303","volume":"14","author":"M Podell","year":"2000","unstructured":"Podell M, March PA, Buck WR, Mathes LE. The feline model of neuroAIDS: understanding the progression towards AIDS dementia. J Psychopharmacol. 2000;14(3):205\u201313.","journal-title":"J Psychopharmacol."},{"issue":"8","key":"204_CR208","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1073\/pnas.87.8.3087","volume":"87","author":"H Egberink","year":"1990","unstructured":"Egberink H, Borst M, Niphuis H, Balzarini J, Neu H, Schellekens H, et al. Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine. Proc Natl Acad Sci U S A. 1990;87(8):3087\u201391.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1\u20132","key":"204_CR209","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-2427(92)90129-E","volume":"35","author":"K Hartmann","year":"1992","unstructured":"Hartmann K, Donath A, Beer B, Egberink HF, Horzinek MC, Lutz H, et al. Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms. Vet Immunol Immunopathol. 1992;35(1\u20132):167\u201375.","journal-title":"Vet Immunol Immunopathol"},{"key":"204_CR210","first-page":"1","volume":"6","author":"KRV Kurapati","year":"2016","unstructured":"Kurapati KRV, Atluri VS, Samikkannu T, Garcia G, Nair MPN. Natural products as Anti-HIV agents and role in HIV-associated neurocognitive disorders (HAND): a brief overview. Front Microbiol. 2016;6:1\u201314.","journal-title":"Front Microbiol."},{"key":"204_CR211","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fphar.2018.00548","volume":"9","author":"B Shal","year":"2018","unstructured":"Shal B, Ding W, Ali H, Kim YS, Khan S. Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer\u2019s disease. Front Pharmacol. 2018;9:548.","journal-title":"Front Pharmacol."},{"issue":"6","key":"204_CR212","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s11095-010-0090-1","volume":"27","author":"T Szekeres","year":"2010","unstructured":"Szekeres T, Fritzer-Szekeres M, Saiko P, J\u00e4ger W. Resveratrol and resveratrol analogues\u2014structure\u2014activity relationship. Pharm Res. 2010;27(6):1042\u20138.","journal-title":"Pharm Res"},{"issue":"1","key":"204_CR213","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.intimp.2004.08.008","volume":"5","author":"XL Bi","year":"2005","unstructured":"Bi XL, Yang JY, Dong YX, Wang JM, Cui YH, Ikeshima T, et al. Resveratrol inhibits nitric oxide and TNF-\u03b1 production by lipopolysaccharide-activated microglia. Int Immunopharmacol. 2005;5(1):185\u201393.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"204_CR214","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/foods6100092","volume":"6","author":"S Hewlings","year":"2017","unstructured":"Hewlings S, Kalman D. Curcumin: a review of its\u2019 effects on human health. Foods. 2017;6(10):92.","journal-title":"Foods."},{"issue":"8","key":"204_CR215","doi-asserted-by":"crossref","first-page":"e70565","DOI":"10.1371\/journal.pone.0070565","volume":"8","author":"L Guo","year":"2013","unstructured":"Guo L, Xing Y, Pan R, Jiang M, Gong Z, Lin L, et al. Curcumin protects microglia and primary rat cortical neurons against HIV-1 gp120-mediated inflammation and apoptosis. PLoS ONE. 2013;8(8):e70565.","journal-title":"PLoS ONE"},{"issue":"6","key":"204_CR216","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4103\/1673-5374.158358","volume":"10","author":"L-L Shen","year":"2015","unstructured":"Shen L-L, Jiang M-L, Liu S-S, Cai M-C, Hong Z-Q, Lin L-Q, et al. Curcumin improves synaptic plasticity impairment induced by HIV-1gp120 V3 loop. Neural Regen Res. 2015;10(6):925.","journal-title":"Neural Regen Res."},{"issue":"3","key":"204_CR217","first-page":"171","volume":"7","author":"Z Gong","year":"2012","unstructured":"Gong Z, Yang L, Tang H, Pan R, Xie S, Guo L, et al. Protective effects of curcumin against human immunodeficiency virus 1 gp120 V3 loop-induced neuronal injury in rats. Neural Regen Res. 2012;7(3):171\u20135.","journal-title":"Neural Regen Res."},{"issue":"15","key":"204_CR218","first-page":"1368","volume":"8","author":"H Tang","year":"2013","unstructured":"Tang H, Pan R, Fang W, Xing Y, Chen D, Chen X, et al. Curcumin ameliorates hippocampal neuron damage induced by human immunodeficiency virus-1. Neural Regen Res. 2013;8(15):1368\u201375.","journal-title":"Neural Regen Res."},{"key":"204_CR219","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s10571-018-0616-3","volume":"38","author":"G Chen","year":"2018","unstructured":"Chen G, Liu S, Pan R, Li G, Tang H, Jiang M, et al. Curcumin attenuates gp120-induced microglial inflammation by inhibiting autophagy via the PI3K pathway. Cell Mol Neurobiol. 2018;38:1465\u201377.","journal-title":"Cell Mol Neurobiol"},{"issue":"11","key":"204_CR220","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1039\/C5FO00485C","volume":"6","author":"S Prasad","year":"2015","unstructured":"Prasad S, Tyagi AK. Curcumin and its analogues: a potential natural compound against HIV infection and AIDS. Food Funct. 2015;6(11):3412\u20139.","journal-title":"Food Funct."},{"key":"204_CR221","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2891-13-17","volume":"13","author":"B Grygiel-G\u00f3rniak","year":"2014","unstructured":"Grygiel-G\u00f3rniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications\u2013a review. Nutr J. 2014;13:17.","journal-title":"Nutr J"},{"issue":"1\u20132","key":"204_CR222","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2005.07.006","volume":"168","author":"PE Polak","year":"2005","unstructured":"Polak PE, Kalinin S, Dello Russo C, Gavrilyuk V, Sharp A, Peters JM, et al. Protective effects of a peroxisome proliferator-activated receptor-\u03b2\/\u03b4 agonist in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2005;168(1\u20132):65\u201375.","journal-title":"J Neuroimmunol"},{"key":"204_CR223","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pnpbp.2014.02.009","volume":"53","author":"JK Barbiero","year":"2014","unstructured":"Barbiero JK, Santiago R, Tonin FS, Boschen S, Da Silva LM, De Paula Werner MF, et al. PPAR-\u03b1 agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson\u2019s disease. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014;53:35\u201344.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry."},{"issue":"1\u20132","key":"204_CR224","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2014.12.027","volume":"349","author":"ZQ Shao","year":"2015","unstructured":"Shao ZQ, Liu ZJ. Neuroinflammation and neuronal autophagic death were suppressed via Rosiglitazone treatment: new evidence on neuroprotection in a rat model of global cerebral ischemia. J Neurol Sci. 2015;349(1\u20132):65\u201371.","journal-title":"J Neurol Sci"},{"issue":"13","key":"204_CR225","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1097\/QAD.0b013e3283081e08","volume":"22","author":"R Potula","year":"2008","unstructured":"Potula R, Ramirez SH, Knipe B, Leibhart J, Schall K, Heilman D, et al. Peroxisome proliferator-activated receptor-g activation suppresses HIV-1 replication in an animal model of encephalitis. AIDS. 2008;22(13):1539\u201349.","journal-title":"AIDS."},{"key":"204_CR226","unstructured":"Huang W, Eum SY, Andr\u00e1s IE, Hennig B, Toborek M. PPAR and PPAR attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities."},{"issue":"4","key":"204_CR227","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/jcbfm.2013.240","volume":"34","author":"W Huang","year":"2014","unstructured":"Huang W, Chen L, Zhang B, Park M, Toborek M. PPAR agonist-mediated protection against HIV Tat-induced cerebrovascular toxicity is enhanced in MMP-9-deficient mice. J Cereb Blood Flow Metab. 2014;34(4):646\u201353.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"204_CR228","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1471-4159.2008.05626.x","volume":"107","author":"W Huang","year":"2008","unstructured":"Huang W, Rha GB, Han MJJ, Eum SY, Andr\u00e1s IE, Zhong Y, et al. PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells. J Neurochem. 2008;107(2):497\u2013509.","journal-title":"J Neurochem."},{"issue":"41","key":"204_CR229","doi-asserted-by":"crossref","first-page":"10683","DOI":"10.1523\/JNEUROSCI.1287-16.2016","volume":"36","author":"MK Mamik","year":"2016","unstructured":"Mamik MK, Asahchop EL, Chan WF, Zhu Y, Branton WG, McKenzie BA, et al. Insulin treatment prevents neuroinflammation and neuronal injury with restored neurobehavioral function in models of HIV\/AIDS neurodegeneration. J Neurosci. 2016;36(41):10683\u201395.","journal-title":"J Neurosci"},{"key":"204_CR230","unstructured":"U.S. National Library of Medicine. Search of: intranasal insulin, HAND\u2014list results\u2014ClinicalTrials.gov."},{"issue":"4","key":"204_CR231","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/hiv.12294","volume":"17","author":"AC Achhra","year":"2016","unstructured":"Achhra AC, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, et al. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D: A: D study. HIV Med. 2016;17(4):255\u201368.","journal-title":"HIV Med."},{"issue":"3","key":"204_CR232","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/hiv.12415","volume":"18","author":"A Silva-Pinto","year":"2017","unstructured":"Silva-Pinto A, Costa A, Serr\u00e3o R, Sarmento A, Abreu P. Ischaemic stroke in HIV-infected patients: a case\u2013control study. HIV Med. 2017;18(3):214\u20139.","journal-title":"HIV Med."},{"issue":"1","key":"204_CR233","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-016-3916-x","volume":"16","author":"OH Divala","year":"2016","unstructured":"Divala OH, Amberbir A, Ismail Z, Beyene T, Garone D, Pfaff C, et al. The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated services. BMC Public Health. 2016;16(1):1\u201311.","journal-title":"BMC Public Health."},{"issue":"1","key":"204_CR234","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W","volume":"32","author":"CM Anderson","year":"2000","unstructured":"Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia. 2000;32(1):1\u201314.","journal-title":"Glia."},{"issue":"4","key":"204_CR235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s13365-014-0258-2","volume":"20","author":"FJ V\u00e1zquez-Santiago","year":"2014","unstructured":"V\u00e1zquez-Santiago FJ, Noel RJ, Porter JT, Rivera-Amill V. Glutamate metabolism and HIV-associated neurocognitive disorders. J Neurovirol. 2014;20(4):315\u201331.","journal-title":"J Neurovirol."},{"issue":"4","key":"204_CR236","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.57.4.671","volume":"57","author":"C Ferrarese","year":"2001","unstructured":"Ferrarese C, Aliprandi A, Tremolizzo L, Stanzani L, De Micheli A, Dolara A, et al. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology. 2001;57(4):671\u20135.","journal-title":"Neurology."},{"issue":"11","key":"204_CR237","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/QAD.0000000000000303","volume":"28","author":"E Cassol","year":"2014","unstructured":"Cassol E, Misra V, Dutta A, Morgello S, Gabuzda D. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. Aids. 2014;28(11):1579\u201391.","journal-title":"Aids."},{"issue":"2","key":"204_CR238","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/viro.1996.0664","volume":"226","author":"J Raber","year":"1996","unstructured":"Raber J, Toggas SM, Lee S, Bloom FE, Epstein CJ, Mucke L. Central nervous system expression of HIV-1 gp120 activates the hypothalamic-pituitary-adrenal axis: evidence for involvement of NMDA receptors and nitric oxide synthase. Virology. 1996;226(2):362\u201373.","journal-title":"Virology"},{"issue":"32","key":"204_CR239","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1523\/JNEUROSCI.1933-04.2004","volume":"24","author":"ER Anderson","year":"2004","unstructured":"Anderson ER. Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis. J Neurosci. 2004;24(32):7194\u20138.","journal-title":"J Neurosci"},{"issue":"9","key":"204_CR240","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/sj.npp.1301615","volume":"33","author":"F Meisner","year":"2008","unstructured":"Meisner F, Scheller C, Kneitz S, Sopper S, Neuen-Jacob E, Riederer P, et al. Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology. 2008;33(9):2228\u201336.","journal-title":"Neuropsychopharmacology."},{"issue":"1","key":"204_CR241","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1310\/hct1101-59","volume":"11","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Navia BA, Marra CM, Singer EJ, Chang L, Berger J, et al. Memantine for AIDS dementia complex: open-label report of ACTG 301. HIV Clin Trials. 2010;11(1):59\u201367.","journal-title":"HIV Clin Trials."},{"issue":"4","key":"204_CR242","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/13550280600873835","volume":"12","author":"G Schifitto","year":"2006","unstructured":"Schifitto G, Yiannoutsos CT, Simpson DM, Marra CM, Singer EJ, Kolson DL, et al. A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. J Neurovirol. 2006;12(4):328\u201331.","journal-title":"J Neurovirol."},{"issue":"1","key":"204_CR243","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12031-015-0651-1","volume":"58","author":"N Nakanishi","year":"2016","unstructured":"Nakanishi N, Kang YJ, Tu S, McKercher SR, Masliah E, Lipton SA. Differential effects of pharmacologic and genetic modulation of NMDA receptor activity on HIV\/gp120-induced neuronal damage in an in vivo mouse model. J Mol Neurosci. 2016;58(1):59\u201365.","journal-title":"J Mol Neurosci"},{"issue":"27","key":"204_CR244","doi-asserted-by":"crossref","first-page":"E2518","DOI":"10.1073\/pnas.1306832110","volume":"110","author":"M Talantova","year":"2013","unstructured":"Talantova M, Sanz-Blasco S, Zhang X, Xia P, Akhtar MW, Okamoto SI, et al. A induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc Natl Acad Sci. 2013;110(27):E2518\u201327.","journal-title":"Proc Natl Acad Sci."},{"issue":"2","key":"204_CR245","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1471-4159.2007.04594.x","volume":"102","author":"N Erdmann","year":"2007","unstructured":"Erdmann N, Zhao J, Lopez AL, Herek S, Curthoys N, Hexum TD, et al. Glutamate production by HIV-1 infected human macrophage is blocked by the inhibition of glutaminase. J Neurochem. 2007;102(2):539\u201349.","journal-title":"J Neurochem"},{"issue":"8","key":"204_CR246","doi-asserted-by":"crossref","first-page":"e0127785","DOI":"10.1371\/journal.pone.0127785","volume":"10","author":"AG Thomas","year":"2015","unstructured":"Thomas AG, Sattler R, Tendyke K, Loiacono KA, Hansen H, Sahni V, et al. High-throughput assay development for cystine-glutamate antiporter (xc-) highlights faster cystine uptake than glutamate release in glioma cells. PLoS ONE. 2015;10(8):e0127785.","journal-title":"PLoS ONE"},{"issue":"7","key":"204_CR247","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/sj.jcbfm.9600438","volume":"27","author":"C Romera","year":"2007","unstructured":"Romera C, Hurtado O, Mallolas J, Pereira MP, Morales JR, Romera A, et al. Ischemic preconditioning reveals that GLT1\/EAAT2 glutamate transporter is a novel PPAR\u03b3 target gene involved in neuroprotection. J Cereb Blood Flow Metab. 2007;27(7):1327\u201338.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"204_CR248","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","volume":"5","author":"C Stancu","year":"2001","unstructured":"Stancu C, Sima A. Statins: mechanism of action and effects. J Cell Mol Med. 2001;5(4):378\u201387.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"204_CR249","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s13365-016-0433-8","volume":"22","author":"A Yadav","year":"2016","unstructured":"Yadav A, Betts MR, Collman RG. Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders. J Neurovirol. 2016;22(5):584\u201396.","journal-title":"J Neurovirol."},{"issue":"3","key":"204_CR250","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1189\/jlb.0811394","volume":"91","author":"DW Williams","year":"2012","unstructured":"Williams DW, Eugenin EA, Calderon TM, Berman JW. Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol. 2012;91(3):401\u201315.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"204_CR251","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/01.wnl.0000325006.84658.e7","volume":"71","author":"JC Probasco","year":"2008","unstructured":"Probasco JC, Spudich SS, Critchfield J, Lee E, Lollo N, Deeks SG, et al. Failure of atorvastatin to modulate CSF HIV-1 infection: results of a pilot study. Neurology. 2008;71(7):521\u20134.","journal-title":"Neurology."},{"issue":"1","key":"204_CR252","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pneurobio.2009.02.002","volume":"88","author":"PJ van der Most","year":"2009","unstructured":"van der Most PJ, Dolga AM, Nijholt IM, Luiten PGM, Eisel ULM. Statins: mechanisms of neuroprotection. Prog Neurobiol. 2009;88(1):64\u201375.","journal-title":"Prog Neurobiol"},{"issue":"6152","key":"204_CR253","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.1241475","volume":"341","author":"Q Tan","year":"2013","unstructured":"Tan Q, Zhu Y, Li J, Chen Z, Han GW, Kufareva I, et al. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science (80-). 2013;341(6152):1387\u201390.","journal-title":"Science (80-)"},{"issue":"3","key":"204_CR254","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QAD.0b013e32834171f8","volume":"25","author":"M Smurzynski","year":"2011","unstructured":"Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, Clifford DB, et al. Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. Aids. 2011;25(3):357\u201365.","journal-title":"Aids."},{"issue":"4","key":"204_CR255","first-page":"137","volume":"19","author":"S Letendre","year":"2011","unstructured":"Letendre S. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med. 2011;19(4):137\u201342.","journal-title":"Top Antivir Med."},{"issue":"2","key":"204_CR256","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2249.2011.04409.x","volume":"166","author":"R Rossi","year":"2011","unstructured":"Rossi R, Lichtner M, de Rosa A, Sauzullo I, Mengoni F, Massetti AP, et al. In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells. Clin Exp Immunol. 2011;166(2):184\u201390.","journal-title":"Clin Exp Immunol"},{"issue":"18","key":"204_CR257","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0000000000000074","volume":"27","author":"KM Kelly","year":"2013","unstructured":"Kelly KM, Beck SE, Pate KAM, Queen SE, Dorsey JL, Adams RJ, et al. Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brain. Aids. 2013;27(18):F21.","journal-title":"Aids."},{"issue":"6","key":"204_CR258","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13365-014-0279-x","volume":"20","author":"LC Ndhlovu","year":"2014","unstructured":"Ndhlovu LC, Umaki T, Chew GM, Chow DC, Agsalda M, Kallianpur KJ, et al. Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associate. J Neurovirol. 2014;20(6):571\u201382.","journal-title":"J Neurovirol."},{"issue":"6","key":"204_CR259","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/hiv.12243","volume":"16","author":"JM Tiraboschi","year":"2015","unstructured":"Tiraboschi JM, Mu\u00f1oz-Moreno JA, Puertas MC, Alonso-Villaverde C, Prats A, Ferrer E, et al. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch. HIV Med. 2015;16(6):388\u201392.","journal-title":"HIV Med."},{"issue":"4","key":"204_CR260","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/QAD.0000000000000951","volume":"30","author":"TM Gates","year":"2016","unstructured":"Gates TM, Cysique LA, Siefried KJ, Chaganti J, Moffat KJ, Brew BJ. Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder. Aids. 2016;30(4):591\u2013600.","journal-title":"Aids."},{"issue":"1","key":"204_CR261","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09540260701878082","volume":"20","author":"BJ Brew","year":"2008","unstructured":"Brew BJ, Letendre SL. Biomarkers of HIV related central nervous system disease. Int Rev Psychiatry. 2008;20(1):73\u201388.","journal-title":"Int Rev Psychiatry."},{"issue":"1","key":"204_CR262","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","volume":"14","author":"LB Ivashkiv","year":"2014","unstructured":"Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14(1):36\u201349.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"204_CR263","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1098-1136(20000201)29:3<273::AID-GLIA8>3.0.CO;2-9","volume":"29","author":"CM McManus","year":"2000","unstructured":"McManus CM, Liu JS, Hahn MT, Hua LL, Brosnan CF, Berman JW, et al. Differential induction of chemokines in human microglia by type I and II interferons. Glia. 2000;29(3):273\u201380.","journal-title":"Glia."},{"issue":"5243","key":"204_CR264","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","volume":"270","author":"F Cocchi","year":"1995","unstructured":"Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1alpha, and MIP-1beta as the major HIV-suppressive factors produced by CD8+ T cells. Science (80-). 1995;270(5243):1811\u20135.","journal-title":"Science (80-)"},{"issue":"5","key":"204_CR265","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1084\/jem.182.5.1517","volume":"182","author":"HT Lu","year":"1995","unstructured":"Lu HT. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48- kD DNA-binding protein, ISGF3-gamma. J Exp Med. 1995;182(5):1517\u201325.","journal-title":"J Exp Med"},{"issue":"3","key":"204_CR266","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ana.410430317","volume":"43","author":"LL Hua","year":"1998","unstructured":"Hua LL, Liu JSH, Brosnan CF, Lee SC. Selective inhibition of human glial inducible nitric oxide synthase by interferon-\u03b1: implications for multiple sclerosis. Ann Neurol. 1998;43(3):384\u20137.","journal-title":"Ann Neurol"},{"issue":"1","key":"204_CR267","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1098-1136(200003)30:1<74::AID-GLIA8>3.0.CO;2-C","volume":"30","author":"LL Hua","year":"2000","unstructured":"Hua LL, Lee SC. Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia. Glia. 2000;30(1):74\u201381.","journal-title":"Glia."},{"issue":"2","key":"204_CR268","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.cdd.4402006","volume":"14","author":"M Kaul","year":"2007","unstructured":"Kaul M, Ma Q, Medders KE, Desai MK, Lipton SA. HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. 2007;14(2):296\u2013305.","journal-title":"Cell Death Differ"},{"issue":"14","key":"204_CR269","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.1073\/pnas.96.14.8212","volume":"96","author":"M Kaul","year":"1999","unstructured":"Kaul M, Lipton SA. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A. 1999;96(14):8212\u20136.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1\u20132","key":"204_CR270","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0165-5728(00)00315-5","volume":"110","author":"R Kitai","year":"2000","unstructured":"Kitai R, Zhao ML, Zhang N, Hua LL, Lee SC. Role of MIP-1\u03b2 and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFN\u03b2. J Neuroimmunol. 2000;110(1\u20132):230\u20139.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"204_CR271","doi-asserted-by":"crossref","first-page":"46514","DOI":"10.1038\/srep46514","volume":"7","author":"VE Thaney","year":"2017","unstructured":"Thaney VE, O\u2019Neill AM, Hoefer MM, Maung R, Sanchez AB, Kaul M. IFN\u03b2 protects neurons from damage in a murine model of HIV-1 associated brain injury. Sci Rep. 2017;7(1):46514.","journal-title":"Sci Rep."},{"issue":"1","key":"204_CR272","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s13311-012-0163-4","volume":"10","author":"CA McGraw","year":"2013","unstructured":"McGraw CA, Lublin FD. Interferon beta and glatiramer acetate therapy. Neurotherapeutics. 2013;10(1):2\u201318.","journal-title":"Neurotherapeutics."},{"issue":"1","key":"204_CR273","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s13365-016-0466-z","volume":"23","author":"AM Anderson","year":"2017","unstructured":"Anderson AM, Lennox JL, Mulligan MM, Loring DW, Zetterberg H, Blennow K, et al. Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals. J Neurovirol. 2017;23(1):106\u201312.","journal-title":"J Neurovirol."},{"issue":"1\u20132","key":"204_CR274","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cytogfr.2012.01.001","volume":"23","author":"C Fritz-French","year":"2012","unstructured":"Fritz-French C, Tyor W. Interferon-\u03b1 (IFN\u03b1) neurotoxicity. Cytokine Growth Factor Rev. 2012;23(1\u20132):7\u201314.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"16","key":"204_CR275","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1097\/QAD.0b013e3282f08c2f","volume":"21","author":"AR Sas","year":"2007","unstructured":"Sas AR, Bimonte-Nelson HA, Tyor WR. Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of Interferon-\u03b1 in the brain. Aids. 2007;21(16):2151\u20139.","journal-title":"Aids."},{"issue":"4","key":"204_CR276","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/jir.2014.0105","volume":"35","author":"CF Kessing","year":"2015","unstructured":"Kessing CF, Tyor WR. Interferon-\u03b1 induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor. J Interf Cytokine Res. 2015;35(4):317\u201324.","journal-title":"J Interf Cytokine Res."},{"issue":"4","key":"204_CR277","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0092-8674(95)90076-4","volume":"81","author":"JA Symons","year":"1995","unstructured":"Symons JA, Alcam\u00ed A, Smith GL. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity. Cell. 1995;81(4):551\u201360.","journal-title":"Cell"},{"issue":"7","key":"204_CR278","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/jir.2013.0072","volume":"34","author":"C Fritz-French","year":"2014","unstructured":"Fritz-French C, Shawahna R, Ward JE, Maroun LE, Tyor WR. The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse model. J Interf Cytokine Res. 2014;34(7):510\u20137.","journal-title":"J Interf Cytokine Res."},{"issue":"11","key":"204_CR279","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/QAD.0000000000001836","volume":"32","author":"R Koneru","year":"2018","unstructured":"Koneru R, Bimonte-Nelson H, Ciavatta V, Haile W, Elmore K, Ward J, et al. Reversing interferon-alpha neurotoxicity in a HIV-associated neurocognitive disorder mouse model. Aids. 2018;32(11):1403\u201311.","journal-title":"Aids."},{"key":"204_CR280","volume-title":"TECFIDERA product monograph","author":"Food and Drug Administration","year":"2014","unstructured":"Food and Drug Administration. TECFIDERA product monograph. Washington: Food and Drug Administration; 2014."},{"issue":"10","key":"204_CR281","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.4049\/jimmunol.1101868","volume":"187","author":"SA Cross","year":"2011","unstructured":"Cross SA, Cook DR, Chi AWS, Vance PJ, Kolson LL, Wong BJ, et al. Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses hiv replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection. J Immunol. 2011;187(10):5015\u201325.","journal-title":"J Immunol."},{"issue":"5","key":"204_CR282","doi-asserted-by":"crossref","first-page":"e36571","DOI":"10.1371\/journal.pone.0036571","volume":"7","author":"EJ Rodriguez-Franco","year":"2012","unstructured":"Rodriguez-Franco EJ, Cantres-Rosario YM, Plaud-Valentin M, Romeu R, Rodr\u00edguez Y, Skolasky R, et al. Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis. PLoS ONE. 2012;7(5):e36571.","journal-title":"PLoS ONE"},{"issue":"16","key":"204_CR283","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1097\/QAD.0000000000000823","volume":"29","author":"YM Cantres-Rosario","year":"2015","unstructured":"Cantres-Rosario YM, Hernandez N, Negron K, Perez-Laspiur J, Leszyk J, Shaffer SA, et al. Interacting partners of macrophage-secreted cathepsin B contribute to HIV-induced neuronal apoptosis. Aids. 2015;29(16):2081\u201392.","journal-title":"Aids."},{"issue":"5","key":"204_CR284","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s13365-015-0358-7","volume":"21","author":"F Zen\u00f3n","year":"2015","unstructured":"Zen\u00f3n F, Cantres-Rosario Y, Adiga R, Gonzalez M, Rodriguez-Franco E, Langford D, et al. HIV-infected microglia mediate cathepsin B-induced neurotoxicity. J Neurovirol. 2015;21(5):544\u201358.","journal-title":"J Neurovirol."},{"issue":"3","key":"204_CR285","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11481-018-9794-5","volume":"13","author":"LJ Rosario-Rodr\u00edguez","year":"2018","unstructured":"Rosario-Rodr\u00edguez LJ, Col\u00f3n K, Borges-V\u00e9lez G, Negr\u00f3n K, Mel\u00e9ndez LM. Dimethyl fumarate prevents HIV-induced lysosomal dysfunction and cathepsin B release from macrophages. J Neuroimmune Pharmacol. 2018;13(3):345\u201354.","journal-title":"J Neuroimmune Pharmacol."},{"issue":"2","key":"204_CR286","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-4159.2005.03520.x","volume":"96","author":"M Nikodemova","year":"2006","unstructured":"Nikodemova M, Duncan ID, Watters JJ. Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and I\u03baB\u03b1 degradation in a stimulus-specific manner in microglia. J Neurochem. 2006;96(2):314\u201323.","journal-title":"J Neurochem"},{"key":"204_CR287","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-5-15","volume":"5","author":"CJ Henry","year":"2008","unstructured":"Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, et al. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflamm. 2008;5:1\u201314.","journal-title":"J Neuroinflamm"},{"issue":"25","key":"204_CR288","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.1073\/pnas.251341998","volume":"98","author":"Y Du","year":"2001","unstructured":"Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease. Proc Natl Acad Sci. 2001;98(25):14669\u201374.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"204_CR289","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jmri.10295","volume":"17","author":"PL Lee","year":"2003","unstructured":"Lee PL, Yiannoutsos CT, Ernst T, Chang L, Marra CM, Jarvik JG, et al. A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. J Magn Reson Imaging. 2003;17(6):625\u201333.","journal-title":"J Magn Reson Imaging"},{"issue":"9","key":"204_CR290","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1073\/pnas.0306239101","volume":"101","author":"YD Teng","year":"2004","unstructured":"Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, Lan S, et al. Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci. 2004;101(9):3071\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"204_CR291","first-page":"14014","volume":"93","author":"AR Amin","year":"1996","unstructured":"Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, et al. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Med Sci. 1996;93:14014\u20139.","journal-title":"Med Sci."},{"issue":"4","key":"204_CR292","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00003495-197509040-00005","volume":"9","author":"RN Brogden","year":"1975","unstructured":"Brogden RN, Speight TM, Avery GS. Minocycline: a review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs. 1975;9(4):251\u201391.","journal-title":"Drugs."},{"issue":"5","key":"204_CR293","doi-asserted-by":"crossref","first-page":"e10523","DOI":"10.1371\/journal.pone.0010523","volume":"5","author":"EM Ratai","year":"2010","unstructured":"Ratai EM, Bombardier JP, Joo CG, Annamalai L, Burdo TH, Campbell J, et al. Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS. PLoS ONE. 2010;5(5):e10523.","journal-title":"PLoS ONE"},{"issue":"12","key":"204_CR294","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/WNL.0b013e31822f0412","volume":"77","author":"N Sacktor","year":"2011","unstructured":"Sacktor N, Miyahara S, Deng L, Evans S, Schifitto G, Cohen BA, et al. Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial. Neurology. 2011;77(12):1135\u201342.","journal-title":"Neurology."},{"issue":"2","key":"204_CR295","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/WNL.0b013e31827b9121","volume":"80","author":"N Nakasujja","year":"2013","unstructured":"Nakasujja N, Miyahara S, Evans S, Lee A, Musisi S, Katabira E, et al. Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment. Neurology. 2013;80(2):196\u2013202.","journal-title":"Neurology."},{"issue":"6","key":"204_CR296","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s13365-014-0292-0","volume":"20","author":"N Sacktor","year":"2014","unstructured":"Sacktor N, Miyahara S, Evans S, Schifitto G, Cohen B, Haughey N, et al. Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment. J Neurovirol. 2014;20(6):620\u20136.","journal-title":"J Neurovirol."},{"issue":"5","key":"204_CR297","first-page":"1","volume":"13","author":"R Gilberto Gonz\u00e1lez","year":"2018","unstructured":"Gilberto Gonz\u00e1lez R, Fell R, He J, Campbell J, Burdo TH, Autissier P, et al. Temporal\/compartmental changes in viral RNA and neuronal injury in a primate model of NeuroAIDS. PLoS ONE. 2018;13(5):1\u201321.","journal-title":"PLoS ONE"},{"issue":"10","key":"204_CR298","doi-asserted-by":"crossref","first-page":"108399","DOI":"10.1371\/journal.pone.0108399","volume":"9","author":"CL Nemeth","year":"2014","unstructured":"Nemeth CL, Glasper ER, Harrell CS, Malviya SA, Otis JS, Neigh GN. Meloxicam blocks neuroinflammation, but not depressive-like behaviors, in HIV-1 transgenic female rats. PLoS ONE. 2014;9(10):108399.","journal-title":"PLoS ONE"},{"issue":"10","key":"204_CR299","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1021\/ja057404h","volume":"128","author":"S Aoki","year":"2006","unstructured":"Aoki S, Watanabe Y, Sanagawa M, Setiawan A, Kotoku N, Kobayashi M, Cortistatins A. B, C, and D, anti-angiogenic steroidal alkaloids, from the marine sponge corticium simplex. J Am Chem Soc. 2006;128(10):3148\u20139.","journal-title":"J Am Chem Soc"},{"issue":"21","key":"204_CR300","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1016\/j.bmc.2007.08.017","volume":"15","author":"S Aoki","year":"2007","unstructured":"Aoki S, Watanabe Y, Tanabe D, Arai M, Suna H, Miyamoto K, et al. Structure-activity relationship and biological property of cortistatins, anti-angiogenic spongean steroidal alkaloids. Bioorg Med Chem. 2007;15(21):6758\u201362.","journal-title":"Bioorg Med Chem."},{"issue":"1","key":"204_CR301","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chom.2012.05.016","volume":"12","author":"G Mousseau","year":"2012","unstructured":"Mousseau G, Clementz MA, Bakeman WN, Nagarsheth N, Cameron M, Shi J, et al. An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription. Cell Host Microbe. 2012;12(1):97\u2013108.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"204_CR302","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1570162X13666150121111548","volume":"13","author":"S Mediouni","year":"2015","unstructured":"Mediouni S, Jablonski J, Paris JJ, Clementz MA, Thenin-Houssier S, Mclaughlin JP, et al. Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice. Curr HIV Res. 2015;13(1):64\u201379.","journal-title":"Curr HIV Res"},{"issue":"1","key":"204_CR303","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/1743-422X-10-358","volume":"10","author":"A Bagashev","year":"2013","unstructured":"Bagashev A, Sawaya BE. Roles and functions of HIV-1 Tat protein in the CNS: an overview. Virol J. 2013;10(1):358.","journal-title":"Virol J."},{"issue":"3","key":"204_CR304","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/026988110001400305","volume":"14","author":"A Nath","year":"2000","unstructured":"Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, et al. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol. 2000;14(3):222\u20137.","journal-title":"J Psychopharmacol."},{"key":"204_CR305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2012.00121","volume":"3","author":"SM Kousik","year":"2012","unstructured":"Kousik SM, Napier TC, Carvey PM. The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Front Pharmacol. 2012;3:1\u201312.","journal-title":"Front Pharmacol."},{"issue":"3","key":"204_CR306","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.celrep.2017.09.080","volume":"21","author":"CF Kessing","year":"2017","unstructured":"Kessing CF, Nixon CC, Li C, Tsai P, Takata H, Mousseau G, et al. In vivo suppression of HIV rebound by didehydro-cortistatin A, a \u201cBlock-and-Lock\u201d strategy for HIV-1 treatment. Cell Rep. 2017;21(3):600\u201311.","journal-title":"Cell Rep."},{"issue":"4","key":"204_CR307","doi-asserted-by":"crossref","first-page":"e00465","DOI":"10.1128\/mBio.00465-15","volume":"6","author":"G Mousseau","year":"2015","unstructured":"Mousseau G, Kessing CF, Fromentin R, Trautmann L, Chomont N, Valente ST. The tat inhibitor didehydro-cortistatin a prevents HIV-1 reactivation from latency. MBio. 2015;6(4):e00465.","journal-title":"MBio."},{"issue":"2","key":"204_CR308","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/14787210.2016.1122525","volume":"14","author":"G Mousseau","year":"2016","unstructured":"Mousseau G, Valente ST. Didehydro-Cortistatin A: a new player in HIV-therapy? Expert Rev Anti Infect Ther. 2016;14(2):145\u20138.","journal-title":"Expert Rev Anti Infect Ther."},{"issue":"1","key":"204_CR309","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.expneurol.2005.04.004","volume":"195","author":"J McGraw","year":"2005","unstructured":"McGraw J, Gaudet AD, Oschipok LW, Kadoya T, Horie H, Steeves JD, et al. Regulation of neuronal and glial galectin-1 expression by peripheral and central axotomy of rat primary afferent neurons. Exp Neurol. 2005;195(1):103\u201314.","journal-title":"Exp Neurol"},{"issue":"1\u20132","key":"204_CR310","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-510X(02)00424-0","volume":"208","author":"M Wada","year":"2003","unstructured":"Wada M, Ono S, Kadoya T, Kawanami T, Kurita K, Kato T. Decreased galectin-1 immunoreactivity of the skin in amyotrophic lateral sclerosis. J Neurol Sci. 2003;208(1\u20132):67\u201370.","journal-title":"J Neurol Sci"},{"issue":"7\u20139","key":"204_CR311","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1023\/B:GLYC.0000014088.21242.e0","volume":"19","author":"J Almkvist","year":"2002","unstructured":"Almkvist J, Karlsson A. Galectins as inflammatory mediators. Glycoconj J. 2002;19(7\u20139):575\u201381.","journal-title":"Glycoconj J"},{"issue":"1","key":"204_CR312","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11481-016-9723-4","volume":"12","author":"R Aalinkeel","year":"2017","unstructured":"Aalinkeel R, Mangum CS, Abou-Jaoude E, Reynolds JL, Liu M, Sundquist K, et al. Galectin-1 reduces neuroinflammation via modulation of nitric oxide-arginase signaling in HIV-1 transfected microglia: a gold nanoparticle-galectin-1 \u201cNanoplex\u201d a possible neurotherapeutic? J Neuroimmune Pharmacol. 2017;12(1):133\u201351.","journal-title":"J Neuroimmune Pharmacol."},{"issue":"10","key":"204_CR313","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ejlt.200600157","volume":"108","author":"HS Hansen","year":"2006","unstructured":"Hansen HS, Petersen G, Artmann A, Madsen AN. Endocannabinoids. Eur J Lipid Sci Technol. 2006;108(10):877\u201389.","journal-title":"Eur J Lipid Sci Technol"},{"issue":"1","key":"204_CR314","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11481-005-9007-x","volume":"1","author":"TW Klein","year":"2006","unstructured":"Klein TW, Cabral GA. Cannabinoid-induced immune suppression and modulation of antigen-presenting cells. J Neuroimmune Pharmacol. 2006;1(1):50\u201364.","journal-title":"J Neuroimmune Pharmacol."},{"issue":"1","key":"204_CR315","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/jpet.109.163055","volume":"333","author":"ES Raborn","year":"2010","unstructured":"Raborn ES, Cabral GA. Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 Is linked to the CB2 cannabinoid receptor. J Pharmacol Exp Ther. 2010;333(1):319\u201327.","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"204_CR316","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/j.1460-9568.2009.06764.x","volume":"29","author":"DA Price","year":"2009","unstructured":"Price DA, Martinez AA, Seillier A, Koek W, Acosta Y, Fernandez E, et al. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease. Eur J Neurosci. 2009;29(11):2177\u201386.","journal-title":"Eur J Neurosci"},{"issue":"8","key":"204_CR317","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI200317652","volume":"111","author":"JL Croxford","year":"2003","unstructured":"Croxford JL, Miller SD. Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212. J Clin Invest. 2003;111(8):1231\u201340.","journal-title":"J Clin Invest."},{"issue":"11","key":"204_CR318","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/brain\/awp239","volume":"132","author":"J Palazuelos","year":"2009","unstructured":"Palazuelos J, Aguado T, Pazos MR, Julien B, Carrasco C, Resel E, et al. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington\u2019s disease excitotoxicity. Brain. 2009;132(11):3152\u201364.","journal-title":"Brain"},{"issue":"9","key":"204_CR319","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.4049\/jimmunol.181.9.6406","volume":"181","author":"T-S Lu","year":"2008","unstructured":"Lu T-S, Avraham HK, Seng S, Tachado SD, Koziel H, Makriyannis A, et al. Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells. J Immunol. 2008;181(9):6406\u201316.","journal-title":"J Immunol."},{"issue":"10","key":"204_CR320","doi-asserted-by":"crossref","first-page":"77577","DOI":"10.1371\/journal.pone.0077577","volume":"8","author":"S Hu","year":"2013","unstructured":"Hu S, Sheng WS, Rock RB. CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120. PLoS ONE. 2013;8(10):77577.","journal-title":"PLoS ONE"},{"issue":"2","key":"204_CR321","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11481-016-9664-y","volume":"11","author":"C Xu","year":"2016","unstructured":"Xu C, Hermes DJ, Mackie K, Lichtman AH, Ignatowska-Jankowska BM, Fitting S. Cannabinoids occlude the HIV-1 Tat-induced decrease in GABAergic neurotransmission in prefrontal cortex slices. J Neuroimmune Pharmacol. 2016;11(2):316\u201331.","journal-title":"J Neuroimmune Pharmacol."},{"issue":"2","key":"204_CR322","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/bph.12478","volume":"171","author":"HK Avraham","year":"2014","unstructured":"Avraham HK, Jiang S, Fu Y, Rockenstein E, Makriyannis A, Zvonok A, et al. The cannabinoid CB2 receptor agonist AM1241 enhances neurogenesis in GFAP\/Gp120 transgenic mice displaying deficits in neurogenesis. Br J Pharmacol. 2014;171(2):468\u201379.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"204_CR323","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11481-010-9225-8","volume":"5","author":"S Gorantla","year":"2010","unstructured":"Gorantla S, Makarov E, Roy D, Finke-Dwyer J, Murrin LC, Gendelman HE, et al. Immunoregulation of a CB2 receptor agonist in a murine model of NeuroAIDS. J Neuroimmune Pharmacol. 2010;5(3):456\u201368.","journal-title":"J Neuroimmune Pharmacol."},{"issue":"4","key":"204_CR324","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11481-014-9554-0","volume":"9","author":"V Purohit","year":"2014","unstructured":"Purohit V, Rapaka RS, Rutter J. Cannabinoid receptor-2 and HIV-associated neurocognitive disorders. J Neuroimmune Pharmacol. 2014;9(4):447\u201353.","journal-title":"J Neuroimmune Pharmacol."},{"issue":"5","key":"204_CR325","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1189\/jlb.1012523","volume":"93","author":"SH Ramirez","year":"2013","unstructured":"Ramirez SH, Reichenbach NL, Fan S, Rom S, Merkel SF, Wang X, et al. Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists. J Leukoc Biol. 2013;93(5):801\u201310.","journal-title":"J Leukoc Biol"},{"issue":"9","key":"204_CR326","doi-asserted-by":"crossref","first-page":"e46178","DOI":"10.1371\/journal.pone.0046178","volume":"7","author":"BB Gelman","year":"2012","unstructured":"Gelman BB, Chen T, Lisinicchia JG, Soukup VM, Carmical JR, Starkey JM, et al. The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment. PLoS ONE. 2012;7(9):e46178.","journal-title":"PLoS ONE."},{"issue":"4","key":"204_CR327","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s004010051139","volume":"99","author":"K Itoh","year":"2000","unstructured":"Itoh K, Mehraein P, Weis S. Neuronal damage of the substantia nigra in HIV-1 infected brains. Acta Neuropathol. 2000;99(4):376\u201384.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"204_CR328","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/13550280600724319","volume":"12","author":"JM Silvers","year":"2006","unstructured":"Silvers JM, Aksenov MY, Aksenova MV, Beckley J, Olton P, Mactutus CF, et al. Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains. J Neurovirol. 2006;12(2):140\u20135.","journal-title":"J Neurovirol."},{"issue":"4","key":"204_CR329","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11481-006-9030-6","volume":"1","author":"BB Gelman","year":"2006","unstructured":"Gelman BB, Spencer JA, Holzer CE, Soukup VM. Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium subjects with HIV encephalitis. J Neuroimmune Pharmacol. 2006;1(4):410\u201320.","journal-title":"J Neuroimmune Pharmacol."},{"issue":"3","key":"204_CR330","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/syn.20594","volume":"63","author":"MJ Ferris","year":"2009","unstructured":"Ferris MJ, Frederick-Duus D, Fadel J, Mactutus CF, Booze RM. In vivo microdialysis in awake, freely moving rats demonstrates HIV-1 tat-induced alterations in dopamine transmission. Synapse. 2009;63(3):181\u20135.","journal-title":"Synapse"},{"issue":"6","key":"204_CR331","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s13365-014-0283-1","volume":"20","author":"KA Meulendyke","year":"2014","unstructured":"Meulendyke KA, Queen SE, Engle EL, Shirk EN, Liu J, Steiner JP, et al. Combination fluconazole\/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease. J Neurovirol. 2014;20(6):591\u2013602.","journal-title":"J Neurovirol."},{"issue":"1","key":"204_CR332","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13365-017-0587-z","volume":"24","author":"N Sacktor","year":"2018","unstructured":"Sacktor N, Skolasky RL, Moxley R, Wang S, Mielke MM, Munro C, et al. Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial. J Neurovirol. 2018;24(1):16\u201327.","journal-title":"J Neurovirol."},{"issue":"4","key":"204_CR333","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00436-006-0313-x","volume":"100","author":"E Hempelmann","year":"2007","unstructured":"Hempelmann E. Hemozoin Biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors. Parasitol Res. 2007;100(4):671\u20136.","journal-title":"Parasitol Res."},{"issue":"11","key":"204_CR334","doi-asserted-by":"crossref","first-page":"1003083","DOI":"10.1371\/journal.pgen.1003083","volume":"8","author":"Z Huang","year":"2012","unstructured":"Huang Z, Srinivasan S, Zhang J, Chen K, Li Y. Discovering thiamine transporters as targets of chloroquine using a novel functional genomics strategy. PLoS Genet. 2012;8(11):1003083.","journal-title":"PLoS Genet"},{"issue":"1","key":"204_CR335","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/hiv.12171","volume":"16","author":"JP Routy","year":"2015","unstructured":"Routy JP, Angel JB, Patel M, Kanagaratham C, Radzioch D, Kema I, et al. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy. HIV Med. 2015;16(1):48\u201356.","journal-title":"HIV Med."},{"issue":"4","key":"204_CR336","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.2012.6936","volume":"308","author":"NI Paton","year":"2012","unstructured":"Paton NI, Goodall RL, Dunn DT, Franzen S, Collaco-moraes Y, Williams IG, et al. Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial. JAMA. 2012;308(4):353\u201361.","journal-title":"JAMA"},{"issue":"6","key":"204_CR337","doi-asserted-by":"crossref","first-page":"e1007061","DOI":"10.1371\/journal.ppat.1007061","volume":"14","author":"C-J Gu","year":"2018","unstructured":"Gu C-J, Borjabad A, Hadas E, Kelschenbach J, Kim B-H, Chao W, et al. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. PLOS Pathog. 2018;14(6):e1007061.","journal-title":"PLOS Pathog."},{"key":"204_CR338","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/088922204322749521","volume":"20","author":"MR Weed","year":"2004","unstructured":"Weed MR, Gold LH, Polis I, Koob GF, Fox HS, Taffe MA. Impaired performance on a rhesus monkey neuropsychological testing battery following simian immunodeficiency virus infection. Aids Res Hum Retrovir. 2004;20:77\u201389.","journal-title":"Aids Res Hum Retrovir"},{"issue":"1","key":"204_CR339","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-017-0829-2","volume":"14","author":"B Ambrosius","year":"2017","unstructured":"Ambrosius B, Faissner S, Guse K, von Lehe M, Grunwald T, Gold R, et al. Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity. J Neuroinflamm. 2017;14(1):51.","journal-title":"J Neuroinflamm"},{"issue":"10","key":"204_CR340","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1172\/JCI72279","volume":"124","author":"AJ Gill","year":"2014","unstructured":"Gill AJ, Kovacsics CE, Cross SA, Vance PJ, Kolson LL, Jordan-Sciutto KL, et al. Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. J Clin Invest. 2014;124(10):4459\u201372.","journal-title":"J Clin Invest."}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-020-00204-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-020-00204-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-020-00204-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T20:04:18Z","timestamp":1625861058000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-020-00204-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":340,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["204"],"URL":"https:\/\/doi.org\/10.1186\/s12987-020-00204-5","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"assertion":[{"value":"11 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Confirmed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}